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	 La	 formación	 del	 Sistema	 Nervioso	 Central	 (SNC)	 y	 la	 diferenciación	 de	 neuronas,	
células	gliales	y	otros	tipos	celulares	que	lo	conforman,	son	procesos	esenciales	que	implican	










Los	 resultados	 obtenidos	 a	 partir	 de	 experimentos	 realizados	 in	 vitro	 e	 in	 vivo	 nos	 han	
permitido	 determinar	 la	 función	 de	 Krox20	 como	 ligasa	 E3	 en	 la	 SUMOilación	 de	 sus	
correpresores,	 las	 proteínas	 Nab.	 Experimentos	 posteriores	 nos	 han	 permitido	 establecer	
una	 función	para	 la	SUMOilación	de	Nab	 in	vivo,	 reprimiendo	 la	 regulación	 transcripcional	
que	Krox20	ejerce	sobre	varios	genes	y	sobre	sí	mismo.	
	 En	una	 segunda	aproximación	hemos	detectado	una	mayor	 acumulación	de	 SUMO	
libre	en	diferenciación	neuronal,	asociada	a	un	menor	nivel	de	SUMOilación	de	proteínas,	lo	
que	nos	ha	 llevado	a	estudiar	 la	 regulación	de	 la	 ruta	de	SUMOilación	en	este	proceso	de	
diferenciación.	Tras	un	análisis	de	 la	expresión	de	 los	distintos	componentes	de	 la	 ruta	de	
SUMOilación	en	neurogénesis,	nuestros	resultados	muestran	un	aumento	en	la	expresión	de	
las	 proteasas	 específicas	 de	 SUMO	 Senp5	 y	 Senp7	 en	 células	 que	 se	 están	 diferenciando.	




hemos	querido	determinar	 si	 existe	un	 cambio	en	el	 patrón	de	 SUMOilación	de	proteínas	




hemos	 utilizado	 la	 técnica	 del	 SILAC	 (Stable	 Isotope	 Labelling	 with	 Amino	 acids	 in	 Cell	
culture)	 para	 posteriormente	 purificar	 proteínas	 SUMOiladas	 en	 estas	 dos	 condiciones,	
empleando	 un	 protocolo	 de	 inmuno-precipitación	 que	 utiliza	 péptidos	 correspondientes	 a	
los	 epítopos	 reconocidos	 por	 los	 anticuerpos	 empleados,	 permitiendo	 así	 la	 elución	
específica	 de	 proteínas	 que	 han	 sido	modificadas	 por	 SUMO	 de	 forma	 endógena.	 Tras	 la	
posterior	 identificación	 de	 proteínas	 por	 espectrometría	 de	 masas	 (MS),	 el	 análisis	 y	
validación	de	los	datos	obtenidos	entre	condiciones	de	proliferación	y	diferenciación	nos	ha	
permitido	detectar	cambios	en	el	estado	de	SUMOilación	de	un	gran	número	de	proteínas	



















factor	 Krox20,	which	 regulates	 hindbrain	 formation	 and	was	 previously	 shown	 to	 interact	
with	 the	 SUMO	 conjugating	 enzyme	 Ubc9.	 Results	 obtained	 in	 experiments	 performed	 in	
vitro	and	 in	vivo	have	evidenced	that	this	 interaction	 is	due	to	the	role	of	Krox20	as	an	E3	
ligase	 for	 SUMOylation	 of	 its	 coregulators,	 the	 Nab	 proteins.	 Further	 experiments	 have	
permitted	 to	 us	 the	 establishment	 of	 a	 functional	 role	 for	 Nab	 SUMOylation	 in	 vivo,	
repressing	the	transcriptional	activity	of	Krox20,	which	in	a	latter	manner	reverts	in	Krox20	
own	repression.	
	 In	a	 second	scientific	approach,	we	have	encountered	 that	neuronal	differentiation	
proceeds	with	net	SUMO	deconjugation	in	the	cell,	which	has	prompted	us	to	study	how	the	
SUMO	modification	 pathway	 is	 regulated	 during	 this	 differentiation	 process.	 After	 a	wide	
expression	 analysis	 of	 the	 different	 components	 from	 the	 SUMOylation	 pathway	 during	
neurogenesis,	 our	 results	 show	 how	 the	 SUMO-specific	 proteases	 Senp5	 and	 Senp7	 are	
upregulated	 in	 differentiating	 cells.	 Further	 experiments	 have	 elucidated	 that	 Senp7	
upregulation	 at	 the	 onset	 of	 neuronal	 differentiation	 is	 indeed	 required	 for	 proper	
progression	of	this	process.	
	 Once	establishing	how	the	SUMOylation	pathway	 is	 regulated	during	neurogenesis,	
we	 also	 wanted	 to	 determine	 whether	 there	 is	 a	 change	 in	 the	 SUMOylation	 pattern	 of	
target	proteins	between	proliferative	and	neuronal	differentiating	cells.	 For	 this	purpouse,	
we	 have	 performed	 a	 Stable	 Isotope	 Labelling	 with	 Amino	 acids	 in	 Cell	 culture	 (SILAC)	




immunoprecipitation	protocol	using	peptides	corresponding	 to	 the	epitopes	 recognized	by	
the	 employed	 antibodies	 that	 permits	 the	 specific	 elution	 of	 endogenously	 SUMOylated	
proteins	 for	 their	 subsequent	 mass	 spectrometry	 (MS)	 identification.	 After	 analysis	 and	
validation	of	the	obtained	data	between	proliferation	and	neuronal	differentiation,	we	have	
detected	 changes	 in	 the	 SUMOylation	 state	 of	 several	 proteins	 that,	 interestingly,	
correspond	 in	 a	 great	 number	 with	 factors	 related	 to	 transcription	 or	 transcriptional	
regulation.	
	 Thus,	 by	 different	 approaches	 we	 have	 demonstrated	 that	 SUMOylation	 is	









	 Cell	 differentiation	processes	are	essential	during	development	and	adult	 life	of	 an	
organism.	Alterations	of	these	processes	have	critical	consequences	such	as	malformations,	




show	 an	 increasing	 incidence	 in	 our	 population.	 A	 great	 number	 of	 proteins,	 mostly	
transcription	factors,	participate	 in	neurogenesis,	both	 in	the	earlier	cell	cycle	exit	and	the	
later	 differentiation	 process.	 Our	 knowledge	 regarding	 factors	 implicated	 in	 the	
transcriptional	 regulation	 that	 leads	 to	 neuronal	 differentiation	 is	 increasing,	 but	 the	
signalling	mechanisms	involved	need	of	further	investigation.	
	 A	signalling	system	that	is	acquiring	more	relevance	regarding	transcriptional	control	
is	 the	 post-translational	modification	 by	 SUMO.	 SUMO	 (Small	Ubiquitin-like	MOdifier)	 is	 a	
small	 polypeptide	 similar	 to	 ubiquitin	 that	 covalently	 binds	 to	 other	 proteins,	 modifying	
them	 in	 a	 post-translational	 way.	 While	 ubiquitylation	 is	 usually	 related	 to	 protein	
degradation	 via	 the	 proteasome,	 SUMOylation	 use	 to	 have	 a	 regulatory	 function.	 In	 this	
manner,	 a	 relevant	 role	 in	 neuronal	 functioning	 has	 been	 described,	 highlighting	 its	





















to	 the	 CNS	 through	 embryogenesis.	 The	 dorsal	 part	 of	 the	 neural	 tube	 is	 populated	 by	 a	







Figure	 I-1:	 neural	 tube	 closure.	 Neurulation	 in	 vertebrates,	 in	 which	 a	 subset	 of	 cells	 from	 the	
ectoderm	 (ec)	 forms	 the	 neural	 plate	 (np)	 (1).	 Then,	 invagination	 of	 the	 neural	 plate	 leads	 to	 the	
formation	of	the	neural	groove	(ng)	and	neural	folds	(nf)	(2),	which	latterly	will	close	dorsally	to	form	
the	neural	tube	(nt)	(3).	A	subset	of	cells	dorsally	close	to	the	neural	tube	form	the	neural	crest	(nc)	




	 The	 neural	 tube	 is	 separated	 from	 the	 ectodermal	 epidermis	 and	 is	 originally	
comprised	by	a	single	layer	of	columnar	shaped	cells	called	neuroepithelial	cells.	All	neurons	

















2013).	 Though	 nuclear	 staining	 of	 the	 neuroepithelial	 cells	 shows	 dispersed	 cell	 nuclei	 at	
different	 levels,	 these	 cells	 form	 a	 unique	 layer	 of	 polarized	 cells	 whose	 nuclei	 distribute	
along	their	apical-basal	axis,	 thus	 forming	a	pseudostratified	monoepithelium	(Chenn,	A	et	
al.,	 1998).	 Neuroepithelial	 cells	 connect	 themselves	 to	 the	 basal	 or	 apical	 face	 of	 the	
neuroepithelium	through	specialized	junctions	towards	the	apical	side,	which	comprises	the	
neural	 tube	 lumen	 (Schoenwolf,	 GC	 and	 Kelley,	 RO,	 1980),	 or	 through	 less	 specialized	
junctions	towards	the	basal	side	(Rodriguez-Boulan,	E	and	Nelson,	WJ,	1989).	As	mentioned,	
the	 pseudostratified	 shape	 of	 this	 cell	 layer	 is	 caused	 by	 nuclei	 displacement	 through	 the	











Figure	 I-2:	 interkinetic	 nuclear	 migration	 of	 neuroepithelial	 cells.	 Schematic	 design	 of	 the	
















which	 will	 eventually	 form	 distinct	 parts	 of	 the	 CNS:	 the	 forebrain	 (prosencephalon),	 the	




dorsal	 side,	 and	 the	 floor	 plate	 at	 the	 ventral	 side	 (Figure	 I-3)	 and,	 together	 with	 the	
notochord,	coordinate	neuronal	differentiation	in	a	spatial-temporal	manner,	depicting	the	
previously	 mentioned	 regions.	 Thus,	 neuronal	 differentiation	 follows	 in	 a	 ventral-dorsal	
manner	in	the	spinal	neural	tube,	whereas	in	the	brain-related	parts,	neurons	originate	first	
in	inner	layers	and	newly	differentiated	progenitors	occupy	outer	layers	as	they	differentiate	
into	 new	 neurons	 (McConnell,	 SK,	 1988).	 After	 generation	 of	 the	 firsts	 neurons,	
neuroepithelium	give	 rise	 to	a	new	compartmentalized	 region,	where	 two	main	structures	
can	be	 recognized:	 the	ventricular	 zone,	 facing	 to	 the	 lumen,	and	 the	mantle	 layer	or	pial	
surface,	 located	 to	 the	outer	part	of	 the	neural	 tube	and	where	neuroepithelial	 cells	have	
migrated	 and	 differentiate	 into	 neurons	 (Figure	 I-3).	 There	 is	 also	 an	 intermediate	 layer	





(below).	 A	 dorsal-ventral	 gradient	 of	 extracellular	 signals	 also	 generates	 different	 sub-
populations	 of	 neurons	 that	 distribute	 with	 a	 territory	 patterning	 in	 the	 neural	 tube	
(reviewed	 in	 (Lewis,	 KE,	 2006)).	 Previously	mentioned	 structures	 in	 the	 ventral	 region	 like	
the	notochord	 first	 and	 the	 floor	plate	 in	 further	 stages	 secrete	 the	Sonic	hedgehog	 (Shh)	
protein,	 while	 dorsal	 structures,	 like	 the	 ectoderm	 first	 and	 the	 roof	 plate	 lately,	 secrete	






been	 described	 to	 differentiate	 mouse	 pluripotent	 cells	 into	 a	 neuronal	 phenotype	
(MacPherson,	PA	et	al.,	1997).	All	together,	these	signals	orchestrate	the	territory	patterning	








Figure	 I-3:	 structure	 specification	of	 the	neural	 tube.	Representation	of	a	transversal	section	from	
the	 neural	 tube	 in	 vertebrates	 during	 neuronal	 differentiation	 and	 neural	 crest	 formation	 and	 the	
associated	 structures	 that	 can	 be	 observed.	 Neural	 progenitors	migrate	 from	 the	 ventricular	 zone	
(VZ)	 to	 the	 pial	 surface	 or	 mantle	 layer	 (ML)	 while	 they	 differentiate	 to	 glial	 cells	 or	 neurons.	
Additionally,	cells	from	the	neural	plate	migrate	and	differentiate	to	form	the	dorsal	root	ganglia	and	

















	 As	 previously	 mentioned,	 neuron	 territory	 patterning	 is	 very	 complex	 during	
development	 of	 the	 neural	 tube	 in	 those	 parts	 that	 will	 give	 rise	 to	 the	 brain	 and	 the	
cerebellum	(forebrain,	midbrain	and	hindbrain).	The	transcription	factor	Krox20	has	a	critical	
role	 in	 hindbrain	 segmentation	 during	 neural	 development	 of	 vertebrates.	 This	
segmentation	 process	 consists	 on	 the	 formation	 of	 7	 to	 8	 segments	 denominated	











Figure	 I-4:	 territory	 expression	 pattern	 of	 Krox20	 and	
related	 genes.	 During	 formation	 of	 the	 hindbrain,	 the	
transcription	 factor	 Krox20	 is	 expressed	 in	 r3	 and	 r5,	
together	with	 its	 corregulators	Nab1	 and	Nab2	 (Nab)	 and	












essential	 for	 the	 establishment	 and	 maintenance	 of	 these	 segments	 during	 hindbrain	

























comprised	 by	 four	 factors,	 firstly	 described	 by	 their	 association	with	 cellular	 proliferation	
response	 to	 different	 growth	 factors	 (Chavrier,	 P	 et	 al.,	 1988).	 A	 common	 feature	 of	 this	
family	of	proteins	is	the	presence	of	three	zinc-finger	domains	to	bind	DNA,	located	to	the	
C-terminal	part	of	the	proteins	(Figure	I-5).	Each	of	these	zinc-finger	domains	allows	for	the	
recognition	 of	 nine	 base	 pairs,	 also	 called	 Egr-response	 elements,	 which	 localize	 in	 the	
promoter	regions	of	Egr-regulated	genes.	Most	of	the	proteins	from	this	family	also	have	an	
R1	 repressor	 domain	 upstream	 to	 the	 zinc-finger	 domains	 (Figure	 I-5).	 The	 R1	 domain	 is	
responsible	for	Krox20	interaction	with	NGFI-A/Egr1-binding	(Nab)	proteins,	Nab1	and	Nab2,	
which	were	initially	identified	as	corepressors	of	Egr	factors	(Russo,	MW	et	al.,	1995).	To	this	
point,	 the	 I268F	single	mutation	 in	 this	domain	has	been	 reported	 to	abrogate	 interaction	
with	Nab	proteins	 (Svaren,	 J	 et	al.,	1998).	Additionally,	 two	acidic	 regions	 located	 towards	
the	N-terminal	part	of	the	protein	and	an	intermediate	region	between	R1	and	one	of	these	
acidic	domains	(Figure	I-5)	have	been	described	to	mediate	transcriptional	regulation	from	a	






corepressive	 function	 has	 been	 established,	 though	 they	 have	 also	 been	 occasionally	
described	 as	 transcriptional	 coactivators	 (Russo,	MW	 et	 al.,	 1995;	 Svaren,	 J	 et	 al.,	 1996).	
Nab1	and	Nab2	show	NLS	sequences	and	share	a	high	sequence	identity,	showing	in	their	N-
terminal	 part	 two	 Nab	 corepressor	 domains	 (NCD),	 each	 one	 being	 related	 with	 specific	
functions	(Figure	I-5).	As	an	example,	the	NCD1	has	been	associated	to	the	interaction	with	
Egr	 factors	 and	 also	 to	 homo-	 and	 heterodimerization	 between	Nab	 proteins.	 In	 fact,	 the	
double	 mutation	 Q64R/H95Q	 has	 been	 shown	 to	 disrupt	 the	 interaction	 with	 Krox20	
through	this	domain	(Svaren,	J	et	al.,	1998).	On	the	other	hand,	the	NCD2,	together	with	the	
C-terminal	 part	 of	 the	 protein	 (CID),	 has	 been	 implicated	 in	 the	 transcriptional	 repressor	
activity	(Figure	I-5).	This	C-terminal	domain	interacts	with	the	chromodomain	helicase	DNA-
binding	protein	4	(CHD4)	subunit	of	the	chromatin	remodelling	complex	NuRD,	resulting	 in	










two	 acidic	 domains	 (AC1	 and	 AC2)	 and	 an	 intermediate	 region	 (Int)	 involved	 in	 transcriptional	
regulation	of	 various	 target	 genes,	 a	 repressor	R1	motif	 that	 also	binds	 to	Nab	proteins	and	 three	
zinc-finger	domains	 for	DNA	binding.	Structural	domains	of	Nab2	are	also	represented,	showing	an	




	 As	 previously	 mentioned,	 some	 of	 the	 structural	 domains	 present	 in	 Krox20	 have	
been	 described	 to	 control	 in	 a	 positive	 or	 a	 negative	 way	 the	 expression	 of	 some	 genes	
during	the	establishment	of	rhombomeres	3	and	5.	This	group	of	genes	include	Krox20	itself,	
the	 genes	 for	 Nab1	 and	 Nab2	 corepressors	 and	 also	 Hox	 genes	 associated	 to	 the	
establishment	of	the	rostral-caudal	axis	of	the	embryo,	the	follistatin	glycoprotein	that	has	
been	 implicated	 in	 rhombomere-to-rhombomere	signalling,	and	adhesion	 factors	 from	the	




I-6)	 (Desmazieres,	 A	 et	 al.,	 2009),	while	Hoxb1	 is	 indirectly	 controlled	 in	 a	 negative	 sense	


















Figure	 I-6:	 Krox20	 regulation	 in	 r3	 and	 r5	 specification	 and	 maintenance	 during	 hindbrain	
development.	Expression	of	Krox20	is	initially	activated	by	various	factors	(X).	Then,	the	transcription	
factor	 activates	 its	 own	 expression	 together	 with	 the	 EphA4	 gene.	 Krox20	 also	 activates	 the	
expression	of	 genes	encoding	 its	Nab	corepressors,	 thus	establishing	a	negative	 feedback	 in	which	
Nab	proteins	repress	the	transcriptional	activity	of	Krox20,	eventually	leading	to	its	own	inactivation.	






	 During	 morphogenesis	 of	 the	 CNS,	 neuroepithelial	 cells	 under	 nuclear	 interkinetic	
migration	undergo	proliferation	while	they	remain	in	the	ventricular	zone	of	the	neural	tube.	
As	 previously	mentioned,	 under	 certain	 circumstances,	 they	 enter	 in	 cell-cycle	 arrest	 and	
start	migrating	to	the	mantle	layer	while	get	differentiated	into	neuron	or	glial	cells.	Taking	
into	 consideration	 that	differentiation	of	neural	progenitors	 requires	 cell-cycle	arrest	after	
G1-phase,	 the	 interaction	 and	 proper	 coordination	 between	 neurogenic	 factors	 and	















(producing	 two	 new	 proliferative	 progenitors),	 asymmetric	 neurogenic	 (producing	 one	
proliferative	progenitor	and	one	postmitotic	cell)	and	symmetric	neurogenic	(producing	two	
postmitotic	cells).	 The	 best-studied	 cellular	 feature	 known	 to	 affect	 neurogenesis	 during	
these	divisions	 is	 the	partitioning	of	determinants	at	cytokinesis,	where	certain	 factors	are	
distributed	 equally	 or	 unequally	 in	 daughter	 cells,	 thus	 creating	 either	 symmetric	 or	
asymmetric	divisions,	respectively	(reviewed	in	(Willardsen,	MI	and	Link,	BA,	2011)).	At	this	
point,	proteins	like	epidermal	growth	factor	receptor	(EGFR)	or	TRIM32	proteins	have	been	
unequally	 detected	 in	 both	 offspring	 cells	 after	 asymmetric	 neurogenic	 divisions	
(Schwamborn,	JC	et	al.,	2009;	Sun,	Y	et	al.,	2005).	Tissue	specificity	of	the	factors	involved	in	
controlling	 these	 divisions	 has	 also	 been	 described,	 as	 neuroepithelial	 cortical	 cells	 that	
undergo	mitosis	and	receive	the	new	centrosome	are	prone	to	migrate	and	differentiate	into	
neurons,	 while	 cells	 with	 the	 former	 centrosome	 remain	 located	 in	 the	 ventricular	 zone	
(Wang,	X	et	al.,	2009).	Another	factor	controlling	proliferative	or	differentiating	state	of	the	
neural	progenitors	 is	the	G1-phase	duration,	as	the	specifying	action	of	determinants	after	
mitosis	 would	 need	 a	 certain	 duration	 time	 of	 the	 G1-phase.	 To	 this	 point,	 it	 has	 been	
described	 how	 shortening	 G1-phase	 reverts	 in	 delayed	 neurogenesis,	 with	 the	 resulting	
increased	generation	of	neural	progenitors	(Lange,	C	et	al.,	2009).	




2)	 family	 of	 proteins.	 DSL	 is	 an	 extracellular	 domain	 present	 in	 these	 proteins	 that	 is	
essential	 to	 interact	with	the	Notch	receptor.	The	Notch	receptor	contains	an	extracellular	
domain	comprising	a	variable	number	of	epidermal	growth	factor	(EGF)	repeats	and	a	linker	
region	 that	 connects	 to	 the	 transmembrane	 domain	 and	 the	 Notch	 intracellular	 domain	
(Nicd).	This	way,	 in	a	group	of	neuroepithelial	cells,	when	the	Notch	receptor	 from	one	of	
the	 cells	 interacts	 with	 a	 DSL	 ligand	 from	 other	 cell,	 the	 Nicd	 domain	 is	 cleavaged	 and	
translocated	to	the	nucleus,	where	it	binds	to	the	DNA-binding	protein	CSL	(CBF1,	Su(H)	and	
LAG-1)	 and,	 together	 with	 Mastermind	 (Mam),	 induces	 CSL-mediated	 transcriptional	
activation	of	the	E(spl)/HES	class	of	genes	(Hes/Her/Esr)	to	maintain	the	proliferative	state	of	
neural	progenitors	(reviewed	in	(Bray,	SJ,	2006)).	Regulation	of	the	Notch	pathway	is	related	




Numb,	 a	 well-characterized	 inhibitor	 of	 the	 Notch	 pathway	 that	 induces	 Notch	 receptor	
endocytosis.	 It	 has	 been	 described	 how	 Numb	 is	 unequally	 distributed	 into	 neural	
progenitors	 from	Drosophila,	 leading	 to	 a	misbalance	 of	 the	Notch	 pathway	 between	 the	
two	 newly	 generated	 neural	 progenitors	 (Berdnik,	 D	 et	 al.,	 2002).	 Interplay	 between	 the	
Notch	 signalling	 pathway	 and	 some	 basic	 helix-loop-helix	 (bHLH)	 proteins	 has	 been	
established	to	occur	during	both	invertebrate	and	vertebrate	neural	development.	
	 Genes	 encoding	 bHLH	 transcription	 factors	 were	 originally	 described	 in	Drosophila	
melanogaster	 and	 related	 genes	 were	 further	 discovered	 in	 vertebrates	 (reviewed	 in	
(Bertrand,	N	et	al.,	2002;	Guillemot,	F,	1999)).	These	genes	have	a	common	bHLH	structural	
motif	that	 is	present	 in	many	transcription	factors,	which	 is	characterized	by	two	α-helices	
separated	by	a	loop.	The	helices	have	been	associated	to	dimerization,	while	the	upstream	
basic	 region	 is	 required	 for	binding	 to	 specific	DNA	sites	with	 the	 sequence	CANNTG,	also	
named	 as	 E-box.	 Various	 families	 of	 Class	 II	 bHLH	 genes	 have	 been	 established	 in	
vertebrates,	 showing	 similarities	 with	 Drosophila	 bHLH	 genes	 and	 specificities	 between	
them.	Thus,	bHLH	vertebrate	genes	with	similarities	with	Drosophila	ato	 (atonal)	would	be	
grouped	 in	the	Atonal	 family	 (Math1	and	Math5),	 the	Neurogenin	family	 (Ngn1,	Ngn2	and	




by	 E2A	 (with	 its	 two	 alternative	 products	 E12	 and	 E47),	 HEB	 and	 E2-2	 in	 vertebrates	
(Johnson,	JE	et	al.,	1992;	Massari,	ME	and	Murre,	C,	2000).	When	heterodimers	are	formed,	
they	 bind	 to	 the	 previously	 mentioned	 E-boxes	 to	 activate	 transcription	 of	 target	 genes.	
Most	 bHLH	 proteins	 act	 as	 transcriptional	 activators,	 with	 only	 few	 exceptions	 like	 Olig2	
(Mizuguchi,	 R	 et	 al.,	 2001;	 Novitch,	 BG	 et	 al.,	 2001).	 As	 their	 action	 depends	 on	 hetero-
dimerization,	a	regulation	system	for	bHLH	proteins	has	been	identified,	consisting	on	HLH-
containing	proteins	that	compete	for	binding	to	E	proteins.	These	competitors	 lack	a	basic	
region	 to	 interact	 with	 DNA,	 thus	 preventing	 transcriptional	 activation.	 To	 this	 point,	 the	
inhibitor	of	differentiation	(Id)	group	of	proteins	have	been	described	to	act	as	regulators	of	














	 bHLH	 proteins	 are	 functionally	 heterogeneous,	 playing	 distinct	 roles	 during	
invertebrate	and	vertebrate	neural	differentiation	pathways,	in	a	fashion	that	often	depends	
on	 the	 cellular	 lineage	 and	 localization.	 Studies	 of	 the	 function	 of	 these	 genes	 have,	 in	
general,	supported	the	division	of	bHLH	genes	into	early	acting	determination	genes	and	late	
acting	differentiation	genes.	 In	 vertebrates,	 early	 acting	determination	genes	or	proneural	
genes	are	expressed	in	proliferative	neuroepithelial	cells	and	are	necessary	and	sufficient	to	


















































Figure	 I-7:	 Neural	 progenitors	 commitment	
and	 differentiation.	 In	 vertebrates,	 neuro-
epithelial	 cells	 are	 already	 specified	 for	 a	
neural	 fate	while	 they	proliferate.	Activation	
of	proneural	bHLH	genes	 in	 these	cells	 leads	
to	their	commitment	into	neural	progenitors	
with	 limited	mitotic	potential	 that,	 following	
subsequent	 activation	 of	 other	 bHLH	 genes,	
will	 finally	 differentiate	 into	 glial	 cells	 or	










	 Proneural	 genes	 comprise	 the	 Achaete-Scute	 genes	 Mash1	 together	 with	 the	
Neurogenin	genes	Ngn1	and	Ngn2	and	the	Atonal	gene	Math1	(reviewed	in	(Bertrand,	N	et	
al.,	 2002)).	 An	 additional	 characteristic	 of	 proneural	 genes	 is	 their	 ability	 to	 induce	 the	





D1	 has	 been	 related	 to	 regulation	 of	 proneural	 genes	 (Lukaszewicz,	 AI	 and	 Anderson,	 DJ,	
2011)	and	that	expression	of	Cdk	(cyclin-dependent	kinases)	inhibitors	such	as	p27	has	been	












Figure	 I-8:	 regulatory	 pathways	 controlling	
neural	 progenitors	 differentiation.	 Through	
lateral	 inhibition,	 a	 regulatory	 loop	 between	 two	
neuroepithelial	 cells	 takes	 place,	 resulting	 in	
upregulation	 of	 Delta	 expression	 by	 proneural	
gene	 products	 and	 downregulation	 of	 proneural	
gene	 expression	 by	 activation	 of	 the	 Notch	
signalling	pathway.	As	 a	 result,	 a	 slight	 increased	
expression	of	proneural	genes	 in	one	of	the	cells,	
which	will	further	become	a	neural	progenitor,	will	revert	in	repression	of	the	proneural	function	in	
the	 neighbouring	 cell	 and	 further	 increase	 of	 proneural	 gene	 expression	 in	 the	 future	 neural	
progenitor.	 In	neural	progenitors,	the	highly	expressed	proneural	genes	ensure	the	cell-cycle	arrest	
by	activation	of	Cdk	(cyclin-dependent	kinases)	inhibitors	and	promote	the	initiation	of	the	neuronal	
differentiation	 programme	 by	 induction	 of	 other	 bHLH	 differentiation	 genes,	 such	 as	 NeuroD	 in	
vertebrates.	 Neuronal	 differentiation	 continues	 with	 the	 subsequent	 activation	 of	 later	








shown	 to	 be	 under	 the	 direct	 control	 of	 proneural	 genes.	 This	 way,	 gain-of-function	
experiments	 in	 chicken	embryos	have	 shown	how	overexpression	of	Ngn	proneural	 genes	
cease	progenitor	division	and	promote	ectopic	neuronal	differentiation	through	activation	of	
the	differentiation	genes	NeuroD	and	NeuroM,	 thus	placing	expression	of	 these	genes	 in	a	
























progenitors	 in	 defined	 regions	 from	 the	 CNS	 (Nieto,	 M	 et	 al.,	 2001;	 Sun,	 Y	 et	 al.,	 2001;	
Tomita,	K	et	al.,	2000).	Interestingly,	the	overexpression	of	late	differentiating	proteins	also	





describe	 how	 expression	 of	 NeuroD2	 is	 necessary	 for	 the	 proper	 development	 of	
hippocampus,	 cortex,	 dentate	 gyrus	 and	 cerebellum.	 It	 expression	 is	 described	 to	 be	
regulated	 by	 Ngn1	 and	 NeuroD,	 situating	 NeuroD2	 in	 a	 latter	 step	 during	 neuronal	
differentiation	(Figure	I-8)	(Lee,	JE,	1997;	Lin,	CH	et	al.,	2004;	Olson,	JM	et	al.,	2001).	Other	
genes	 encoding	 non-bHLH	 proteins	 also	 coordinate	 differentiation	 of	 neural	 progenitors.	
Examples	of	this	are	Ebf	genes,	which	encode	for	proteins	with	an	atypical	helix-loop-helix	
(HLH)	domain.	Ebf3,	 for	 instance,	 is	expressed	 in	an	extended	fashion	during	cell-cycle	exit	
and	differentiation	of	neural	progenitors	in	the	chick	hindbrain	and	spinal	cord	regions	from	
the	neural	tube	(Garcia-Dominguez,	M	et	al.,	2003).	





JF,	 1999).	 Genes	 encoding	 for	 bHLH	 proteins	 with	 no	 proneural	 function	 have	 also	 been	
implicated	 in	 the	 specification	 of	 neuronal	 identity,	 for	 example	 in	 retina	 (reviewed	 in	
(Cepko,	 CL,	 1999)).	 An	 interesting	 feature	 of	 neuron	 specification	 is	 the	 necessity	 of	
interaction	between	bHLH	and	homeobox	proteins.	 In	this	way,	 it	has	been	described	how	
amacrine	cells	establishment	requires	the	coexpression	of	NeuroD	or	Math3	 together	with	
the	 homeobox	 gene	 Chx10	 or	 how	 bipolar	 cells	 are	 generated	 after	 NeuroD	 or	Math3	













ubiquitin	 fold	 (globular	 β-grasp	 fold)	 and	 a	 characteristic	 C-terminal	 Gly-Gly	 motif	 that	 is	
exposed	 after	 proteolytic	 maturation.	 In	 the	 years	 1996	 and	 1997	 SUMO	 was	 firstly	
identified	as	an	Ubiquitin-like	polypeptide,	being	responsible	for	the	reversible	modification	
of	 the	 nucleoporin	 Ran	 GTPase-activating	 protein	 1	 (RanGAP1)	 (Mahajan,	 R	 et	 al.,	 1997;	
Matunis,	MJ	 et	 al.,	 1996).	 Since	 then,	 our	 knowledge	on	 SUMO	has	 greatly	 increased	and	
thousands	 of	 new	 targets	 have	 been	 identified,	 allowing	 the	 assignation	 of	 a	 role	 for	
SUMOylation	in	many	aspects	of	the	eukaryotic	cell	life.	
	 SUMO	is	present	 in	eukaryotes,	being	SUMOylation	an	essential	process	 in	virtually	
all	of	them,	and	is	highly	conserved	through	species.	Only	one	isoform	of	the	gene	has	been	
identified	 in	 lower	 eukaryotes	 like	 Saccharomyces	 cerevisiae,	 where	 SUMO	 is	 encoded	 by	
SMT3	(Johnson,	ES	et	al.,	1997).	On	the	contrary,	more	than	one	gene	encoding	for	SUMO	is	
















SUMO3	are	 free	 in	 the	 cell	 and	 rapidly	 conjugated	 to	proteins	 in	 response	 to	 a	 variety	of	
stress	conditions	 (Tempe,	D	et	al.,	2008).	There	are,	however,	examples	of	 target	proteins	
such	 as	 topoisomerase	 II	 and	 CAAT/enhancer-binding	 protein-beta	 (C/EBPβ)	 that	 are	
specifically	modified	by	SUMO2/3	under	non-stress	conditions	(Azuma,	Y	et	al.,	2003;	Eaton,	
EM	and	Sealy,	 L,	2003).	 SUMO4	 is	encoded	by	a	 sequence	 located	within	an	 intron	of	 the	
human	TAB2	gene	and	it	has	been	described	to	be	highly	expressed	in	kidney	cells	(Wei,	W	






for	 its	 conjugation	 to	 the	 target	 proteins.	 So-called	 SUMOylation	 takes	 place	 when	 the	
C-terminus	part	of	SUMO	is	covalently	attached	to	the	ε-amino	group	of	a	lysine	present	in	a	
target	 protein	 by	 a	 thioester	 bond.	 This	 lysine	 is	 usually	 located	 within	 the	 amino	 acid	
consensus	Ψ-K-X-E,	with	Ψ	 being	 an	 aliphatic	 branched	 amino	 acid	 and	 X	 any	 amino	 acid	
(Hay,	RT,	2005).	A	SUMOylation	consensus	site	is	 located	within	SUMO2/3	sequence,	while	
this	 site	 is	 not	 present	 in	 SUMO1.	 Consistent	 with	 this	 observation,	 SUMO2/3	 has	 been	
described	 to	 form	SUMO	chains	 in	vitro	 and	 in	 vivo,	while	 this	 is	not	 the	 case	 for	 SUMO1	
(Bohren,	KM	et	al.,	2004;	Tatham,	MH	et	al.,	2001).	Nevertheless,	it	has	to	be	pointed	that	
not	 all	 proteins	 containing	 a	 SUMOylation	 consensus	 site	 are	 SUMOylated,	 and	 not	 all	
proteins	modified	by	 SUMO	contain	a	 SUMOylation	 consensus	 site.	 Indeed,	 some	variants	
for	the	canonical	consensus	have	been	described,	 including	an	 inverted	consensus	motif,	a	
consensus	 motif	 with	 a	 hydrophobic	 cluster,	 a	 negatively	 charged	 amino	 acid-dependent	
motif	 and	 some	extended	phosphorylation-dependent	motifs	 (Hietakangas,	V	 et	 al.,	 2006;	
Matic,	I	et	al.,	2010;	Picard,	N	et	al.,	2012;	Rodriguez,	MS	et	al.,	2001;	Yang,	SH	et	al.,	2006).	
These	 data	 indicates	 that	 other	 aspects,	 such	 as	 subcellular	 localization	 or	 proper	
presentation	 of	 the	 SUMOylation	 site	 in	 the	 3D	 structure	 of	 the	 target	 protein,	 may	 be	
required	for	the	covalent	attachment	of	SUMO	to	its	target.	
	 It	has	been	previously	stated	that	proteins	are	SUMOylated	when	SUMO	is	covalently	
attached	 to	 them.	 However,	 SUMO	 is	 also	 capable	 of	 interacting	with	 proteins	 through	 a	




SIM	 consists	 on	 short	 hydrophobic	 stretches	 with	 the	 sequence	 (V/I)-X-(V/I)-(V/I)	 or	
(V/I)-(V/I)-X-(V/I),	N-	or	C-terminally	flanked	by	serine	residues	and/or	by	a	stretch	of	acidic	
amino	 acids	 (Hecker,	 CM	 et	 al.,	 2006;	 Song,	 J	 et	 al.,	 2005).	 SIMs	 have	 been	 identified	 in	
numerous	SUMO	targets	and	they	have	been	described	to	account	for	SUMOylation	of	the	
target	and	 to	 serve	as	mediators	 for	downstream	events	 that	 require	 the	 interaction	with	





	 SUMOylation	appears	 to	be	a	highly	 specific	process	 taking	 into	consideration	both	
the	 selection	 of	 protein	 targets	 as	 well	 as	 the	 timing	 and	 dynamics	 of	 the	 modification.	
Though	the	mechanisms	involved	in	the	SUMO	modification	pathway	start	to	be	elucidated,	
many	 aspects	 of	 both	 specificity	 and	 dynamics	 still	 need	 to	 be	 studied.	 Among	 the	
similarities	that	SUMO	shares	with	ubiquitin,	their	modification	pathway	is	one	of	them.	In	
the	 SUMOylation	 pathway	 (Figure	 I-9),	 some	 of	 the	 enzymes	 that	 participate	 in	 the	
modification	by	SUMO,	such	as	E1	and	E2,	have	sequences	with	similarities	to	their	ubiquitin	
counterparts	and	are	highly	conserved	in	eukaryotes.	
	 Like	 ubiquitin,	 all	 SUMO	 paralogs	 are	 synthesized	 as	 an	 inactive	 precursor	
polypeptide	that	needs	to	be	maturated	and	activated,	in	order	to	become	conjugatable	to	
target	 proteins.	 The	 initial	 maturation	 is	 conducted	 by	 SUMO-specific	 isopeptidases	 that	
performs	 a	 proteolitic	 cleavage	 in	 the	 C-terminus	 part	 of	 the	 molecule,	 exposing	 the	
previously	mentioned	Gly-Gly	(Figure	I-9)	(reviewed	in	(Hay,	RT,	2005)).	
	 Once	maturated,	 the	C-terminus	part	of	 SUMO	needs	 to	be	activated	 in	a	 reaction	
that	is	performed	by	the	E1	enzyme.	The	SUMO	E1	enzyme	is	a	heterodimer	comprised	by	
the	SUMO-activating	enzyme	subunit	1	(SAE1,	also	known	as	Aos1)	and	the	SUMO-activating	









of	 the	 SUMO-AMP	 bond	 by	 a	 conformational	 change	 in	 the	 SEA2	 subunit	 leads	 to	 the	







At	 the	 beginning,	 recently	 synthesised	 SUMO	 needs	 to	 be	 proteolitically	 maturated	 by	 a	 SUMO-
specific	 protease	 (SENP)	 in	 order	 to	 be	 conjugatable.	 Maturated	 SUMO	 is	 then	 activated	 by	 the	
SUMO	 E1	 enzyme	 (SAE1/SAE2)	 in	 an	 ATP-dependent	 manner,	 by	 formation	 of	 a	 thioester	 bond	
between	the	C-terminal	glycine	of	SUMO	and	the	catalytic	cysteine	(C)	of	the	SAE2	subunit.	SUMO	is	
then	 transferred	 to	 the	E2	conjugating	enzyme	 (Ubc9)	by	 the	 formation	of	another	 thioester	bond	
with	 the	 enzyme,	 for	 finally	 being	 conjugated	 to	 an	 acceptor	 lysine	 (K)	 of	 the	 target	 protein,	































2004)).	 The	 mentioned	 following	 step	 on	 the	 SUMOylation	 pathway	 consists	 on	 a	
transesterification	reaction,	 in	which	activated	SUMO	is	transferred	from	the	SAE2	subunit	






In	 spite	of	 this,	Ubc9	 is	 capable	of	performing	a	 function	notably	distinguishable	 from	 the	
action	of	ubiquitin	conjugating	enzymes;	Ubc9	is	involved	in	the	direct	recognition	of	many	
SUMO	 substrates,	 but	 the	 target	 lysine	 must	 be	 included	 in	 the	 previously	 mentioned	






surface	 (Bernier-Villamor,	 V	 et	 al.,	 2002).	 Interestingly,	 when	 the	 acceptor	 lysine	 is	 not	
included	in	a	consensus	site,	the	presence	of	an	E3	ligase	(Yunus,	AA	and	Lima,	CD,	2009)	or	
the	existence	of	SIMs	(Chang,	CC	et	al.,	2011;	Meulmeester,	E	et	al.,	2008;	Zhu,	J	et	al.,	2008)	












ligase	 activity	 have	 been	 discovered	 up	 to	 date	 (Kerscher,	 O	 et	 al.,	 2006).	 Interestingly,	
though	all	of	them	increase	SUMOylation	in	a	substrate	specific	manner,	it	is	described	how	




changes	 its	 orientation	 to	 increase	 its	 proximity	 and	 affinity	 for	 the	 acceptor	 lysine.	 As	 a	
result,	this	lysine	is	capable	of	performing	a	nucleophilic	attack	that	results	in	the	formation	
of	 an	 isopeptidic	 bond	 with	 the	 acceptor	 lysine,	 covalently	 attaching	 SUMO	 to	 its	 target	
protein	(reviewed	in	(Flotho,	A	and	Melchior,	F,	2013)).	The	most	studied	E3	SUMO	ligases	
that	have	been	described	to	show	this	last	activity	could	be	numbered	as	an	extent	group	of	
proteins	 containing	 Siz/PIAS-RING	 (SP-RING)	 domains	 and	 the	 Ran-binding	 protein	 2	
(RanBP2).	
	 The	SP-RING	domain	consists	on	a	type	of	zinc-finger	domain	classically	associated	to	
DNA	 binding	 that	 is	 highly	 conserved	 among	 eukaryotes	 and	 shares	 similarities	 with	 the	
RING	 finger	domain	present	 in	many	E3	ubiquitin	 ligases.	 In	 this	manner,	 some	of	 the	SP-
RING	E3	ligases	include	Siz1,	Siz2,	methyl	methanesulphonate-sensitivity	protein	21	(Mms21)	
and	molecular	 zipper	 protein	 3	 (Zip3)	 in	 yeast	 and	 the	protein	 inhibitor	 of	 activated	 STAT	
(PIAS)	family	of	proteins	in	mammals,	that	in	mouse	and	human	are	represented	at	least	by	
PIAS1,	PIASx	(PIAS2),	PIAS3	and	PIASγ	(PIAS4).	However,	two	splice	variants	are	described	for	
PIASx;	 PIASxα	 and	 PIASxß	 ((Chung,	 CD	 et	 al.,	 1997;	 Liu,	 B	 et	 al.,	 1998)	 and	 reviewed	 in	
(Rytinki,	MM	 et	 al.,	 2009)).	 Proteins	 that	 comprise	 the	PIAS	 family	 in	mammals	 are	highly	
conserved,	 regarding	 the	 first	430	N-terminal	amino	acids,	 though	their	 total	 length	varies	
from	 PIAS4	 with	 510	 amino	 acids	 to	 PIAS1	 with	 651.	 In	 all	 of	 these	 ligases,	 five	 well	
established	structural	domains	have	been	identified:	an	N-terminal	SAP	(scaffold	attachment	
factor-A/B,	acinus	and	PIAS)	domain,	a	PINIT	motif,	the	previously	mentioned	SP-RING,	a	SIM	
and	 a	 C-terminal	 region	 enriched	 in	 serine/threonine	 (S/T)	 (Figure	 I-10A).	 Notably,	 the	
SP-RING	domain	has	been	described	to	be	necessary	for	the	interaction	with	Ubc9	(reviewed	
in	(Rytinki,	MM	et	al.,	2009)).	The	target	proteins	for	SUMOylation	would	interact	with	the	




located	 in	 PIAS	 ligases	 has	 not	 been	 related	with	 a	 SUMO	 ligase	 function	 and,	 indeed,	 its	
deletion	on	PIASxα	has	been	described	to	stimulate	its	ligase	activity	(Kotaja,	N	et	al.,	2002).	
It	is	also	worth	noting	that	specificity	for	SUMO	paralogs	has	been	poorly	described	for	these	






Figure	 I-10:	 E3	 SUMO	 ligases	 and	 PIAS1	 structure	 domains.	
(A)	 Structural	 domains	 of	 human	 PIAS1	 E3	 ligase.	 The	 SAP	
domain	has	been	related	to	sequence-specific	DNA	binding.	A	
PINIT	domain	has	been	associated	 to	 the	nuclear	 localization	
of	 the	protein.	The	 following	SP-RING	domain	 is	described	to	
be	responsible	for	binding	to	the	E2	conjugating	enzyme	Ubc9.	
A	 SIM	 and	 a	 C-terminal	 region	 enriched	 in	 serine	 and	




	 As	 previously	 mentioned,	 RanBP2	 (also	 known	 as	 Nup358)	 sums	 to	 the	 list	 of	 E3	
SUMO	 ligases	 that	have	been	widely	 studied	 (Figure	 I-10B),	 but	does	not	 resembles	 to	E3	
ubiquitin	ligases,	as	it	does	not	contain	neither	HECT	nor	RING	domains,	typical	features	of	
many	ubiquitin	ligases	(Pichler,	A	et	al.,	2004).	RanBP2	is	a	large	protein	of	358	kDa	located	
in	 the	 Nuclear	 Pore	 Complex	 (NPC).	 Its	 in	 vitro	 activity	 requires	 only	 one	 of	 two	 closely	
spaced	amino	acid	repeat	regions	(IR1	and	IR2)	that,	combined	with	a	short	spacing	region	
(M),	can	bind	to	the	Ubc9-SUMO	thioester	bond	(Saitoh,	H	et	al.,	2002;	Tatham,	MH	et	al.,	
2005).	 In	 vivo,	 together	with	 SUMOylated	Ran	GTPase-activating	 protein	 1	 (RanGAP1)	 and	
Ubc9,	forms	an	E3	SUMO	ligase	complex	capable	of	 interacting	with	multiple	proteins	that	
are	 prone	 for	 nucleocytoplasmic	 transport	 through	 the	 NPC	 and	 could	 be	 possible	
SUMOylation	targets	(Hamada,	M	et	al.,	2011;	Werner,	A	et	al.,	2012).	
	 Other	 proteins	whose	 E3	 SUMO	 ligase	 activity	 has	 been	 also	 studied	 comprise	 the	
human	 polycomb	 protein	 Pc2	 (Kagey,	 MH	 et	 al.,	 2003),	 the	 class	 II	 histone	 deacetylases	
(HDACs	II)	and	the	Topors	proteins	(Gregoire,	S	and	Yang,	XJ,	2005;	Hammer,	E	et	al.,	2007;	


















	 In	 eukaryote	 cells,	 SUMO-specific	 peptidases	 are	 responsible	 of	 three	mayor	 tasks:	
performing	 the	 initial	 proteolytic	 cleavage	 for	 SUMO	 maturation,	 removing	 single	 SUMO	
molecules	 from	modified	 proteins	 and	 depolymerising	 SUMO	 chains.	 Contrary	 to	 what	 is	
described	for	ubiquitin,	where	a	large	number	of	specific	isopeptidases	have	been	identified	
and	 grouped	 in	 various	 classes	 of	 proteases	 (Reyes-Turcu,	 FE	 et	 al.,	 2009;	Wilkinson,	 KD,	
1997),	a	small	number	of	SUMO	proteases	have	been	identified	up	to	date,	belonging	to	the	
group	of	cysteine	proteases.	In	this	regard,	the	most	well	studied	SUMO	proteases	comprise	
two	 ubiquitin-like	 protein-specific	 proteases	 (Ulp1	 and	 Ulp2)	 that	 have	 been	 identified	 in	
yeast	 and	 six	 sentrin-specific	 proteases	 (SENPs)	 (SENP1-3	 and	 SENP5-7),	 identified	 in	
humans.	The	first	identified	SUMO	isopeptidase	was	yeast	Ulp1	(Li,	SJ	and	Hochstrasser,	M,	




family	of	cysteine	proteases,	 showing	a	characteristic	His-Asp-Cys	catalytic	 triad	present	 in	
the	adenovirus	processing	protease	(AVP)	(Li,	SJ	and	Hochstrasser,	M,	1999).	The	active	site	
of	Ulp1	 is	comprised	by	a	ß-sheet	 in	addition	to	two	helixes,	creating	a	central	cleft	 in	the	
protein	 with	 the	 approximate	 length	 of	 a	 lysine	 side	 chain.	 The	 cysteine	 included	 in	 the	
catalytic	triad	is	located	at	the	N-terminus	of	the	central	helix,	whereas	histidine	and	aspartic	
acid	 residues	 from	 the	 active	 site	 are	 both	 located	 in	 the	 ß-sheet.	 The	 C-terminal	Gly-Gly	
motif	of	SUMO	is	located	to	this	cleft	and	orientates	in	a	cis	configuration,	establishing	a	turn	
in	 the	 C-terminal	 end	 of	 immature	 SUMO	 precursors	 or	 in	 the	 isopeptide	 bond	 of	









Figure	 I-11:	 structure	 domains	 in	 SUMO-specific	 isopeptidases.	 Structure	 domains	 and	 length	 (in	
amino	 acids)	 of	 SUMO-specific	 isopeptidases	 present	 in	 yeast	 and	 vertebrates,	 showing	 the	
N-terminal	domains	 involved	 in	subcellular	 localization	 (green)	and	the	C-terminal	catalytic	domain	
(yellow),	indicating	the	key	histidine	(H)	and	cysteine	(C)	residues	from	the	active	sites.	Putative	SIM	












these	 proteins	 for	 conjugated	 SUMO	 isoforms	 has	 been	 shown	 not	 to	 be	 strong	 in	 vitro	









































































and	 SENP5	 localize	 to	 the	 nucleolus	 and	 SENP6	 and	 SENP7	 localize	 to	 the	 nucleoplasm	
(reviewed	in	(Hickey,	CM	et	al.,	2012)).	In	contrary	to	the	C-terminus,	the	N-terminal	regions	
are	 poorly	 conserved	 (Figure	 I-11).	 The	presence	of	 putative	 SIMs	 in	 non-catalytic	 regions	
has	also	been	described	for	Ulp2	and	most	of	SENP	proteases.	Though	SUMO	is	bound	to	the	
catalytic	 domain	 by	 other	 surfaces,	 these	 SIMs	 could	 increase	 the	 affinity	 for	 SUMO	 or	
SUMO	chains,	or	could	account	for	a	correct	orientation	of	the	SUMOylated	protein	 in	the	
protease.	
	 Recently,	 three	 new	 SUMO-specific	 proteases	 have	 been	 described	 in	 humans,	
deSUMOylating	isopeptidase	1	(DESI1),	DESI2	(Shin,	EJ	et	al.,	2012)	and	the	ubiquitin-specific	
protease-like	 1	 (USPL1)	 (Schulz,	 S	 et	 al.,	 2012).	 DESI1	 and	 DESI2	 proteins	 share	 little	
sequence	identity	with	Ulp	and	SENP	proteases	and	belong	to	the	PPPDE	(permuted	papain	
fold	 peptidases	 of	 double-stranded	 RNA	 viruses	 and	 eukaryotes)	 class	 of	 proteases.	
Interestingly,	 its	 catalytic	 activity	 is	 based	 on	 their	 ability	 to	 dimerise,	 thus	 comprising	 a	



















identified	 in	 the	 cell	 cytoplasm,	 nuclear	 targeting	 is	 required	 for	 most	 of	 them	 to	 be	
modified	by	SUMO	in	vivo	(Rodriguez,	MS	et	al.,	2001).	
	 Several	works	also	establish	an	association	for	SUMO	with	DNA	repair.	SUMOylation,	
together	 with	 ubiquitylation,	 has	 been	 shown	 to	 orchestrate	 the	 cellular	 responses	 to	 a	
variety	of	DNA	aberrations,	 due	either	 to	 exogenous	damage	or	 to	natural	 occurring	DNA	
metabolism,	 such	 as	 postreplication	 repair,	 base-excision	 repair	 and	 the	 repair	 of	 most	
cytotoxic	 double-strand	breaks	 (reviewed	 in	 (Jackson,	 SP	 and	Durocher,	D,	 2013)).	 Several	
works	 in	 yeast	 and	 higher	 eukaryotes	 have	 established	 genetic	 associations	 with	
chromosome	condensation,	cohesion	and	segregation	during	mitosis	and	meiosis	for	every	
component	 of	 the	 SUMOylation	 pathway	 (reviewed	 in	 (Seeler,	 JS	 and	 Dejean,	 A,	 2003)),	
adding	modification	by	SUMO	to	the	factors	that	maintain	genetic	stability	in	the	eukaryotic	
cell.	
	 SUMOylation	 has	 shown	 to	 be	 necessary	 for	 regulation	 and	 stabilization	 of	 some	
proteins,	 as	 it	 has	 been	 studied	 how	 the	 same	 lysine	 residues	 can	 be	modified	 in	 certain	
circumstances	either	by	SUMOylation,	ubiquitylation,	acetylation	or	phosphorylation.	A	well-
known	example	of	 this	competition	mechanism	 is	 Iκbα,	where	SUMOylation	of	 lysine	21	 is	
shown	 to	 inhibit	 phosphorylation-induced	 ubiquitylation	 and	 subsequent	 proteasomal	
degradation	(Desterro,	JM	et	al.,	1998).	
	 One	of	the	most	 important	functions	attributed	to	SUMOylation	 is	the	modification	
of	 transcription	 factors	 in	 order	 to	 control	 gene	 expression.	 This	 way,	 modification	 by	
SUMO1	 has	 been	 typically	 related	 to	 transcriptional	 repression.	 Certain	 exceptions	 are	
known,	 like	 the	 increase	 in	 target	 gene	 expression	 mediated	 by	 heat	 shock	 transcription	
factors	HSF1	and	HSF2	when	modified	by	SUMO1	(Goodson,	ML	et	al.,	2001;	Hong,	Y	et	al.,	
2001).	But	as	said,	many	are	the	examples	where	repressor	domains	present	in	transcription	





2009)).	 SUMO2/3	 though,	has	been	mostly	 shown	not	 to	be	conjugated	 to	proteins	under	
normal	conditions,	but	to	rapidly	modify	a	variety	of	proteins	during	the	cellular	response	to	
various	 stresses	 like	 hypoxia	 (Yang,	W	 et	 al.,	 2012)	 or	 heat	 stress	 (Castoralova,	M	 et	 al.,	
2012).	
	 Finally,	 though	not	being	a	 cellular	 function	per	 se,	 it	 is	 important	 to	mention	how	
evolution	has	made	possible	for	pathogens	to	take	advantage	of	the	SUMOylation	pathway	
during	 infection.	As	 the	SUMO	modification	pathway	only	 comprises	one	 single	E1	and	E2	
enzyme,	 any	 interference	with	 these	 enzymes	has	 remarkable	 effects.	 In	 fact,	 it	 has	 been	
described	how	certain	viruses	and	bacteria	enhance	their	infection	by	targeting	host	E1	or	E2	






in	 (Martin,	 S	 et	 al.,	 2007)).	 As	 an	 example,	 SUMOylation	 of	 the	 postsynaptic	 scaffolding	




factor	 2	 (MEF2)	 turns	 to	 be	 a	 transcriptional	 repressor	 or	 an	 activator	 depending	 on	 its	
SUMOylated	or	not	SUMOylated	state,	respectively	(reviewed	in	(Beg,	AA	and	Scheiffele,	P,	
2006)).	 In	addition	to	this,	not	only	substrates	but	also	enzymes	of	the	SUMO	modification	
pathway	 like	 SAE1,	 Ubc9,	 SENP1	 and	 SENP6,	 have	 been	 detected	 in	 rat	 synaptosomes	
(reviewed	in	(Luo,	J	et	al.,	2013)).	
	 The	implication	of	SUMO	with	neurodegenerative	diseases	that	generate	due	to	the	
accumulation	 of	 aberrant	 proteins,	 like	 Alzheimer	 and	 Parkinson	 diseases,	 has	 also	 been	
described.	 In	 these	 cases,	 SUMOylation	 seems	 to	 prevent	 degradation	 of	 these	 aberrant	
products	by	competition	with	ubiquitylation	and	proteasome-mediated	degradation.	 In	the	
case	 of	 Alzheimer,	 pathological	 progression	 has	 been	 related	 to	 synaptic	 failure	 and	 later	




Both	 amyloid-ß	 and	 tau	 proteins	 have	 been	 shown	 to	 be	 SUMOylated	 and	 alterations	 in	
enzymes	of	the	SUMO	pathway,	like	SAE2	or	SENP3,	have	been	reported	in	affected	tissues	
(reviewed	in	(Lee,	L	et	al.,	2013)).	Parkinson	disease	is	not	defined	by	a	single	pathology,	but	
rather	 comprises	 a	 variety	 of	 syndromes.	 Though	 little	 is	 known	 about	 the	 causes	 of	 the	
disease,	 most	 of	 the	 cases	 are	 characterized	 by	 the	 presence	 of	 Lewy	 bodies	 containing	




	 SUMOylation	 is	 associated	 with	 transcriptional	 regulation,	 a	 critical	 feature	 in	
neuronal	development.	Up	to	date,	few	reports	have	linked	SUMOylation	with	the	control	of	
this	 process.	 Thus,	 SUMOylation	 of	 the	 transcription	 factor	 SoxN	 has	 been	 proposed	 to	
repress	its	transcriptional	activity,	which	is	necessary	for	the	proper	formation	of	the	CNS	in	
Drosophila	(Savare,	J	et	al.,	2005).	On	the	other	hand,	SUMOylation	of	Braf35,	a	subunit	of	
the	 LSD1-CoREST	 histone	 demethylase	 complex	 has	 been	 shown	 to	 be	 necessary	 for	 the	
maintenance	of	the	undifferentiated	state	of	neuronal	precursors	(Ceballos-Chavez,	M	et	al.,	
2012).	 Despite	 these	 findings,	 the	 establishment	 of	 clear	 implication	 of	 additional	 SUMO	
targets	and	of	components	of	the	SUMOylation	pathway	in	orchestrating	different	aspects	of	












1) To	 analyse	 the	 function	 of	 the	 interaction	 between	 Krox20	 and	 Ubc9	 during	
hindbrain	development.	
	
2) To	 study	 the	 regulation	 of	 the	 SUMOylation	 pathway	 and	 its	 components	 in	 the	
context	of	neurogenesis.	
	










	 Understanding	 the	mechanisms	 involved	 in	 the	 neural	 development	 is	 an	 arduous	
task	 since	 it	 involves	 the	 comprehension	 of	 numerous	 pathways	 and	 signalling	 systems	
implicated	 in	 the	 tight	 regulation	 and	 control	 of	 this	 process.	Many	 of	 these	mechanisms	
remain	unclear.	
	 A	signalling	system	that	is	acquiring	more	relevance	regarding	transcriptional	control	
is	 the	 post-translational	 modification	 by	 SUMO.	 SUMOylation	 is	 essential	 in	 vertebrates.	
Adding	 this	 consideration	 to	 its	 relevance	 in	 transcriptional	 control	 and	 many	 other	
functions	 in	 the	 cell,	 it	 is	 likely	 to	 think	 that	 this	 post-translational	modification	might	 be	
implicated	 in	 the	 neuronal	 differentiation	 process.	 In	 this	 work,	 we	 analyse	 the	 role	 of	
SUMOylation	 in	 three	 different	 scenarios	 of	 neural	 development,	 to	 shed	 light	 on	 the	
mechanisms	involved	in	this	complex	process.	
	 The	first	scenario	focuses	on	the	formation	of	the	hindbrain	in	vertebrates,	where	an	
intricate	 and	 highly	 regulated	 compartmentalizing	 process	 takes	 place	 during	 the	
development	 of	 this	 region	 of	 the	 embryonic	 central	 nervous	 system.	 Starting	 from	
preliminary	 results	 obtained	 from	 a	 two-hybrid	 experiment,	 we	 have	 described	 a	 system	
where	SUMOylation	plays	a	regulatory	role	during	hindbrain	formation.	
	 The	second	scenario	turns	into	the	neural	tube.	The	development	of	this	structure	is	
simpler	 than	 that	of	 the	hindbrain	and	we	have	 taken	advantage	of	a	variety	of	 tools	and	
models	 to	 analyse	 how	 does	 the	 SUMOylation	 machinery	 behave	 during	 the	 neuronal	
differentiation	processes	that	take	place	during	its	formation.	
	 Once	 having	 investigated	 the	 behaviour	 of	 the	 SUMO	 modification	 pathway	 in	
neurogenesis,	 the	 last	 scenario	 focuses	on	determine	which	 target	proteins	have	a	 role	 in	
neuronal	 differentiation	 through	 regulation	 by	 SUMO.	 For	 this	 purpose,	 a	 Stable	 Isotope	
Labelling	 with	 Amino	 acids	 in	 Cell	 culture	 (SILAC)	 experiment	 comparing	 the	 SUMO	
proteome	 of	 proliferative	 and	 differentiating	 P19	 cells	 has	 been	 done	 to	 initially	 identify	










	 From	 a	 previous	 two-hybrid	 screening	 based	 on	 mouse	 Krox20	 lacking	 the	 two	
transactivation	 domains	 present	 in	 this	 transcription	 factor	 and	 an	 8.5	 dpc	 mouse	
embryo	cDNA	library	(Garcia-Dominguez,	M	et	al.,	2006),	seven	positive	clones	were	isolated	
corresponding	 to	 the	 SUMO-conjugating	 enzyme	 Ubc9	 from	mouse.	 Validation	 of	 one	 of	





Figure	 R-1:	 Two-hybrid	 validation	 of	 the	 interaction	 between	 Krox20	 and	 Ubc9.	 (A)	 Yeast	 was	
cotransformed	 with	 the	 indicated	 constructs	 and	 grown	 in	 selective	 and	 non-selective	 media	 for	
two-hybrid	 experiment.	 Bait	 and	 prey	 constructs	 were	 based	 on	 the	 Gal4	 DNA-binding	 domain	
(G4BD)	and	Gal4	activation	domain	(G4AD)	vectors,	respectively.	(B)	Pull-down	of	in	vitro	translated	
and	radioactively	labelled	Krox20	was	performed	against	0.5	µg	of	purified	glutathione	S-transferase	



































Figure	R-2:	The	 zinc-finger	domain	of	Krox20	mediates	 its	 interaction	with	Ubc9.	Krox20	deletion	
constructs	were	cotransformed	in	yeast	as	indicated,	following	growth	in	selective	and	non-selective	






However,	 it	 has	 been	 previously	 reported	 that	 Krox20	 is	 not	 modified	 by	 SUMO	 (Garcia-
Dominguez,	 M	 et	 al.,	 2006).	 Ubc9	 also	 interacts	 with	 SUMO	 ligases	 as	 these	 proteins	
facilitate	 the	 transfer	of	 SUMO	 from	Ubc9	 to	 the	 target	protein.	We	 therefore	 speculated	
that	Krox20	might	recruit	Ubc9	to	function	as	a	ligase	in	the	SUMOylation	of	other	proteins.	
To	this	point,	Nab1	and	Nab2	have	been	described	as	Krox20	corepressors	(Russo,	MW	et	al.,	
1995;	Svaren,	 J	et	al.,	1996)	 that	 represent	good	candidates.	 Indeed,	amino	acid	sequence	
analysis	 revealed	 two	 SUMOylation	 consensus	 sites	 in	 mouse	 Nab2	 (K379	 and	 K517)	




























situ	 ß-gal	 activity	 was	 analysed	 to	 determine	 interaction	
(blue)	 or	 absence	 of	 interaction	 (white)	 between	 Nab2	
and	Ubc9	by	two-hybrid	experiment,	when	cotransformed	









	 To	 test	Nab	proteins	modification	by	 SUMO,	we	performed	 SUMOylation	 assays	 in	
293T	 cells	 transfected	 with	 Flag-tagged	 Nab	 expression	 constructs	 and	 analysed	 the	 cell	
extracts	by	Western	blot	(Figure	R-5).	The	only	transfection	of	Nab2	resulted	in	detection	of	





























performed	 transfecting	293T	 cells	with	 the	 indicated	expression	 constructs	of	different	 versions	of	
Krox20	and	SUMO,	as	well	 as	 Flag-tagged	Nab.	After	 cell	 harvesting,	denaturing	protein	extraction	
was	 performed	 to	 analyse	 Nab	 SUMOylation	 by	 Western	 blot	 using	 antibodies	 against	 the	 Flag	
epitope.	Blue	arrowheads	indicate	unmodified	Nab	while	white	or	green	arrowheads	indicate	diverse	
Nab	 SUMOylated	 forms.	 (A,	 D)	 Nab1	 and	Nab2	 are	modified	 by	 SUMO1	when	 cotransfected	with	
Krox20,	 and	 SUMOylation	 is	 enhanced	 by	 addition	 of	 low	 amounts	 of	 SUMO1.	 Nab2	 shows	 no	
modification	when	low	amounts	of	SUMO1	are	cotransfected	in	the	absence	of	Krox20.	(B)	To	assess	
Nab2	modification	 by	 SUMO1	 in	 the	 presence	 of	 Krox20,	 different	 tagged	 versions	 of	 SUMO1	 are	
transfected.	 An	 increase	 in	 SUMOylated	 Nab2	 bands	 is	 observed	when	 cotransfecting	 GFP-tagged	
SUMO1	 in	 comparison	 to	 His-tagged	 SUMO1.	 (C)	 Specificity	 of	 Nab	 modification	 by	 SUMO1	 is	












































construct	 (Figure	R-5C).	Nab1	was	 also	 SUMOylated	by	 SUMO1	 in	 the	presence	of	 Krox20	
(Figure	R-5D).	 As	Nab1	 and	Nab2	 are	 highly	 homologous	 and	have	 been	 shown	 to	 display	
similar	 functions	 (Svaren,	 J	 et	al.,	1996),	we	 restricted	 the	 following	experiments	 to	Nab2,	
from	now	referred	to	as	Nab.	As	a	next	step,	we	wanted	to	assess	the	specificity	of	Krox20	
SUMO	 ligase	 action.	 In	 transfection	 experiments,	 Nab	 was	 specifically	 modified	 in	 the	
presence	 of	 Krox20,	 as	 a	 non-related	 transcription	 factor	 (NeuroM)	 had	 no	 effect.	
Additionally,	we	generated	an	Ubc9	mutant	encompassing	a	single	mutation	in	the	catalytic	
site	 (Ubc9C93S)	 responsible	 for	 its	 non-covalent	 interaction	 with	 SUMO.	 Interestingly,	






Figure	 R-6:	 Specificity	 of	 Krox20	
SUMO	 ligase	 action	 in	 Nab	
SUMOylation.	 The	 indicated	
expression	 constructs	 were	
transfected	 in	 293T	 cells	 for	
SUMO	modification	 assays	 in	 the	
same	 conditions	 shown	 in	
Figure	R-5.	 (A)	 SUMOylation	 of	
Flag-tagged	 Nab	 is	 disrupted	
when	 trans-fecting	 a	 catalitic	
Ubc9C93S	mutant	in	the	presence	
of	 Krox20.	 Krox20	 and	 no	 other	
transcription	 factor	 as	 NeuroM	
specifically	 enhances	 Nab	 SUMO-
ylation	 by	 SUMO1.	 Blots	with	 HA	
antibodies	 are	 shown	 to	 check	
expression	 of	 Krox20	 or	NeuroM.	
Expression	 of	 the	 Ubc9	 C93S	
mutant	 is	 shown	 using	 Flag	 anti-
bodies.	 (B)	 Modification	 of	 Flag-
tagged	 Nab	 is	 not	 altered	 when	
different	ligases	of	the	PIAS	family	
were	 cotransfected	 and	 com-
pared	 to	 Nab	 SUMOylation	 in	 the	 only	 presence	 of	 Krox20.	 His-tagged	 SUMO1	 is	 included	 in	 all	
tested	conditions.	Blots	using	HA	antibodies	are	shown	to	check	PIAS	expression.	
–	 +	–	 –	 –	
kDa	
–	 –	–	 HA-Krox20	+	 +	
His-SUMO1	–	 +	+	 +	 +	





























mutant	 (KR2)	 is	 not	 modified	 by	 SUMO1.	
(A)	Localization	of	Flag-tagged	Nab	wild	type	
and	 KR2	 mutant	 was	 analysed	 by	 immuno-
fluorescence	of	293T	cells	after	 transfection	
of	 the	 indicated	 expression	 constructs.	 Flag	
antibodies	 were	 used	 to	 reveal	 Nab	
localization	 in	 the	 cells	 (red).	 Nuclei	 was	
visualized	 by	 DAPI	 counterstaining	 (blue).	
(B)	The	 interaction	 of	 both	 wild	 type	 Nab	
and	 KR2	 mutant	 with	 Krox20	 was	 analysed	
by	 two-hybrid	 experiments.	 For	 this,	 the	
indicated	 expression	 constructs	 were	
transformed	 in	 yeast	 and	 ß-galactosidase	
activity	was	measured	 and	 indicated	 in	Miller	 units	 corresponding	 to	means	of	 three	 independent	
experiments	 ±	 s.d.	 (C)	 The	 indicated	 expression	 constructs	 were	 transfected	 in	 293T	 cells	 to	 test	
SUMOylation	of	Nab	KR2	mutant.	After	cell	harvesting,	denaturing	protein	extracts	were	analysed	by	










































	 Overexpression	 of	 the	 protein	 inhibitor	 of	 activated	 STAT	 (PIAS)	 proteins	 was	 also	
tested,	not	significantly	modifying	Nab	SUMOylation	in	the	presence	of	Krox20	(Figure	R-6B).	
To	 check	 whether	 the	 two	 consensus	 sites	 identified	 in	 Nab	 were	 responsible	 of	 its	
SUMOylation,	we	designed	a	double	mutant	of	the	putative	target	lysines,	K379R	and	K517R	
(KR2).	To	test	that	Nab	cellular	properties	were	not	altered	by	these	two	mutations,	cellular	
localization	was	 analysed	on	one	hand	by	 immunofluorescence	and	 compared	 to	 the	wild	
type	Nab,	showing	in	both	cases	a	nuclear	 localization	as	revealed	by	DAPI	counterstaining	
(Figure	R-7A).	On	 the	other	hand,	Nab-Krox20	 interaction	 capabilities	were	not	 altered	by	
these	 mutations	 as	 shown	 by	 quantification	 of	 ß-galactosidase	 activity	 in	 two-hybrid	
experiments	 (Figure	 R-7B).	 As	 expected,	 this	 mutant	 was	 not	 SUMOylated	 after	
cotransfection	of	293T	cells	with	Krox20	and	His-SUMO1	(Figure	R-7C).	
	 We	 next	 investigated	 the	 involvement	 of	 Krox20-Nab	 interaction	 in	 Nab	
SUMOylation,	as	would	be	expected	for	a	SUMO	E3	ligase,	by	transfection	of	293T	cells.	The	
single	 mutation	 I268F	 in	 Krox20	 and	 the	 double	 mutation	 Q64RH95Q	 in	 Nab	 have	 been	
shown	 to	 abrogate	 Krox20-Nab	 interaction	 (Svaren,	 J	 et	 al.,	 1998).	 We	 found	 that	 both	
mutations	prevented	SUMOylation	(Figure	R-8A).	By	contrast,	neither	Krox20	nor	the	I268F	
mutant	 showed	 any	 effect	 in	 general	 SUMOylation,	 as	 monitored	 by	 modification	 of	 the	
carboxyl	 terminal	 part	 of	 RanGAP1	 (RanGAP1-C-ter),	 a	 well-known	 SUMO1	 substrate	
(Figure	R-8B).	
	 To	 shed	 light	 on	 the	 endogenous	mechanisms	 that	 involve	 SUMO	 ligase	 action	 of	
Krox20	in	the	cell,	we	turned	to	the	P19	cell	line,	as	these	cells	express	both	Krox20	and	Nab.	






blot,	as	the	amount	of	modified	protein	 is	very	 limited	 in	comparison	with	the	unmodified	
form	 (Hay,	 RT,	 2005).	 Thus,	 we	 decided	 to	 transfect	 P19	 cells	 with	 low	 amounts	 of	 the	
His-SUMO1	expression	vector	to	analyse	Nab	SUMOylation	after	pull-down	of	the	His-tagged	






induction	 of	 Krox20	 (Figure	 R-9B).	 SUMOylation	 of	 endogenous	Nab	was	 also	 observed	 in	
pull-down	 experiments	 after	 transfection	 of	 a	 Krox20	 expression	 vector	 without	 serum	
stimulation	 (Figure	 R-9C).	 Finally,	 knockdown	 of	 induced	 Krox20	 by	 a	 combination	 of	 two	








Figure	 R-8:	 Physical	 interaction	
between	 Nab	 and	 Krox20	 is	
necessary	 for	 Nab	 SUMOylation.	
SUMOylation	 assays	 were	 per-
formed	by	transfection	of	293T	with	
the	indicated	expression	constructs.	
Cells	 were	 harvested	 24h	 after	
transfection	and	denaturing	protein	
extracts	were	analysed	by	Western	
blot.	 (A)	 SUMOylation	 of	 Nab	 and	
Krox20	 non-interacting	 mutants	
was	analysed	by	Western	blot	using	
Flag	 antibodies	 against	 the	 Flag-
tagged	 Nab.	 The	 absence	 of	
SUMOylated	 Nab	 bands	 in	 the	
presence	 of	 the	 mutants	 shows	
how	 Krox20	 and	 Nab	 need	 to	
interact	 for	 proper	 SUMO	 ligase	
and	 target	 function,	 respectively.	
Blots	with	HA	antibodies	are	shown	
as	 controls	 for	 the	 expression	 of	
Krox20	 constructs.	 (B)	 Analysis	 of	
Flag-tagged	 RanGAP1-Cter	 (Ran)	
SUMOylation	 was	 conducted	 on	
transfected	293T	cells	to	discard	an	indirect	effect	of	Krox20IF	mutant	on	overall	SUMO	modification	
in	the	cell.	Western	blot	with	Flag	antibodies	showed	how	Ran	was	equally	modified	by	SUMO	in	the	
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Expression	 levels	 of	Nab2	 and	Krox20	were	 analysed	by	 quantitative	 PCR	 in	 proliferating	 P19	 cells	
after	RNA	isolation	(grey	bars).	Expression	levels	of	absent	(GFP)	and	well-expressed	genes	(Oct4)	in	
this	condition	are	also	shown	as	controls.	Nab2	and	Krox20	expression	was	also	analysed	after	serum	




show	 1.5%	 input	 of	 the	 indicated	 proteins.	 Note	 that	 Krox20	 antibodies	 also	 reveal	 a	 non-specific	
upper	 band	 (*).	 (B)	 Endogenous	Nab	 SUMOylation	was	 visualized	 after	 transfection	of	His-SUMO1	
and	induction	of	Krox20	expression	by	serum	stimulation.	Blot	using	antibodies	against	endogenous	
Krox20	 is	 shown	 as	 a	 control	 of	 Krox20	 expression	 induction.	 Endogenous	 Nab	 expression	 is	 also	
shown.	 (C)	 SUMOylation	 of	 endogenous	 Nab	was	 also	 observed	 when	 P19	 cells	 were	 transfected	














































































	 To	 definitively	 demonstrate	 that	 Krox20	 functions	 as	 a	 SUMO	 ligase	 for	 Nab,	 we	
performed	in	vitro	SUMOylation	assays	with	proteins	purified	from	E.	coli	(Figure	R-10A	and	
R-10B).	 As	 illustrated	 in	 Figure	 R-10C,	 SUMOylation	 of	 Nab	 took	 place	 in	 vitro	 and	 was	
indeed	 dependent	 on	 the	 presence	 of	 Krox20.	 Furthermore,	 chemiluminescence	
measurement	from	the	bands	detected	by	Western	blot	and	comparison	with	the	amount	of	
loaded	 protein	 revealed	 that	 0.3x10-12	 mol	 of	 Krox20	 were	 sufficient	 to	 modify	 at	 least	





Figure	 R-10:	 In	 vitro	 SUMOylation	 assay	 to	 assess	 the	 SUMO	 ligase	 role	 of	 Krox20	 in	 Nab	
modification	by	SUMO1.	(A,	B)	Coomassie	blue	staining	of	recombinant	fusion	proteins	purified	from	
E.	 coli.	Mouse	E1	monomers	 (red	arrows),	Ubc9,	Krox20	and	human	matured	SUMO1	 (SUMO1GG)	
were	 purified	 as	 GST-fusion	 proteins	 and	 SUMO1GG	 was	 later	 excised	 from	 GST.	 Nab-Flag	 was	
purified	as	a	His-tagged	version	using	a	nickel	affinity	matrix.	(C)	In	vitro	SUMOylation	assay	with	the	
previously	 shown	 purified	 proteins	 to	 test	 modification	 by	 SUMO1GG	 of	 300	 ng	 of	 Nab	 in	 the	
presence	of	15	ng	of	Krox20	by	Western	blot	using	Flag	antibodies.	SUMOylated	products	correspond	









































	 SUMOylation	 has	 been	 related	 to	 many	 roles	 in	 the	 cell,	 being	 modification	 by	
SUMO1	mostly	connected	to	transcriptional	regulation	(Seeler,	 JS	and	Dejean,	A,	2003).	As	
Nab	 SUMOylation	 by	 Krox20	 has	 been	 shown	 to	 be	 specific	 for	 SUMO1	 (Figure	 R-5C),	we	
next	 investigated	 whether	 SUMO1	 can	 be	 recruited	 to	 a	 Nab	 regulated	 sequence	 in	 the	
context	of	chromatin.	We	chose	to	examine	the	Id4	promoter	because	it	has	been	previously	
shown	 to	be	 regulated	by	 the	Krox20–Nab	complex	 (Mager,	GM	 et	al.,	 2008).	 In	P19	cells	
growing	 under	 serum	 deprivation,	 chromatin	 immunoprecipitation	 (ChIP)	 experiments	
analysing	SUMO1	incorporation	revealed	that	serum	addition	led	to	a	threefold	increase	in	
SUMO	 levels	 associated	 to	 the	 Id4	 promoter	 (Figure	 R-11).	 To	 investigate	 whether	 Nab	
SUMOylation	was	 involved,	 cells	were	 transfected	with	wild	 type	Nab	 or	 the	 KR2	mutant	
immediately	after	serum	deprivation.	Whereas	in	the	presence	of	wild	type	Nab	the	increase	











Id4	 promoter,	 analysed	 by	 chromatin	
immunoprecipitation	 (ChIP)	 assays	 and	
quantitative	PCR	of	P19	cells	transfected	with	
Flag-tagged	 wild	 type	 Nab	 or	 with	 the	 KR2	
mutant.	Untransfected	P19	were	also	included	
in	 the	 experiments	 (–).	 SUMO1	 incorporation	
was	 measured	 under	 normal	 growth	
conditions	 (white	 bars)	 or	 after	 serum	
































of	 Nab.	 To	 this	 point,	 it	 is	 worth	 nothing	 to	 mention	 that,	 among	 the	 numerous	 roles	
attributed	 to	 SUMO	 in	 the	 eukaryotic	 cell,	 SUMOylation	 has	 been	 mostly	 linked	 to	
transcriptional	repression	(Garcia-Dominguez,	M	and	Reyes,	 JC,	2009).	Thus,	we	wanted	to	
analyse	 how	 Nab	 SUMOylation	 correlates	 with	 its	 interaction	 with	 CHD4.	 After	





Figure	 R-12:	 Nab	 interaction	 with	 CHD4	 is	 not	
altered	 by	 mutation	 of	 Nab	 SUMOylation	 sites.	
293T	 cells	 were	 transfected	 with	 expression	
vectors	 of	 a	 HA-tagged	 version	 of	 the	 Nab-
interacting	 domain	 from	 CHD4	 and	 with	 Flag-
tagged	 versions	 of	 Nab	 and	 the	 KR2	mutant.	 Cell	
extracts	 were	 subjected	 to	 immunoprecipitation	










Nab	 expression	 constructs.	 The	 results	 showed	 how	 the	 reporter	 was	 activated	 when	
transfecting	 the	 Krox20	 expression	 construct	 but	 downregulated	when	 also	 cotransfecting	
Nab,	which	could	be	modified	by	the	endogenous	SUMO1.	A	more	severe	downregulation	is	
























Figure	 R-13:	 Nab	 SUMOylation	 represses	 Krox20	
transcriptional	activity	in	P19	cells.	A	LacZ	reporter	
under	the	control	of	an	EphA4	element,	responsive	
to	 Krox20,	 was	 cotransfected	 with	 the	 indicated	
expression	constructs	to	analyse	the	transcriptional	
activity	 of	 Krox20	 in	 P19	 cells.	 Relative	 units	 of	 ß-
galactosidase	 activity	 were	 normalized	 to	 the	
values	 obtained	 in	 cells	 only	 cotransfected	 with	





to	 perform	 a	 functional	 analysis	 in	 the	 hindbrain.	 In	 this	 embryonic	 structure,	 Krox20	
regulates	various	genes	during	the	formation	of	rhombomeres	3	and	5	(r3	and	r5),	including	
itself	and	Nab	genes	(Chomette,	D	et	al.,	2006;	Desmazieres,	A	et	al.,	2009;	Giudicelli,	F	et	
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developmental	 stages,	 mostly	 appear	 in	 even	 numbered	 rhombomeres.	 These	 results	
confirmed	 that	 Ubc9	 is	 expressed	 in	 rhombomeres	 3	 and	 5.	 A	 detailed	 analysis	 of	 Ubc9	
expression	 revealed	 that,	 as	 shown	 in	 the	 previous	 in	 situ	 hybridization	 experiments,	 a	






Figure	 R-14:	 Expression	 of	 Ubc9	 in	 the	
hindbrain.	 Flat	 mounts	 from	 the	 hindbrain	 of	
HH13-14	 chick	 embryos	 processed	 to	 analyse	
the	 expression	 of	 various	 markers	 in	
rhombomeres	3	to	5.	(A,	B)	In	situ	hybridization	
using	 antisense	 RNA	 probes	 against	 Ubc9	
(purple)	 or	 against	 Ubc9	 (orange)	 and	 Krox20	
(purple).	 (C,	 D)	 Immunofluorescence	 using	
antibodies	against	Ubc9	 (red)	and	EphA4	 (green)	 (C)	 or	against	Ubc9	 (blue)	and	 the	neural	marker	
ßIII-tubulin	 (red)	 (D).	 (E)	 Detail	 of	 an	 immuno-fluorescence	 experiment	 as	 described	 in	 (C).	

































A	 et	 al.,	 2009)	 and	 was	 confirmed	 in	 our	 experiments	 (Figure	R-15A,	 15B	 and	 15I).	









Figure	 R-15:	 Nab	 SUMOylation	 represses	 Krox20	
transcriptional	activity	in	the	chick	hindbrain.	(A-H)	Flat	mount	
of	 the	 hindbrain	 from	HH13-14	 chick	 embryos	 electroporated	
on	 the	 left	 side	with	 the	 indicated	 expression	 constructs.	 24h	
later,	 embryos	 were	 harvested	 and	 immunofluorescence	
experiments	 were	 conducted	 to	 analyse	 the	 transcriptional	
activity	of	Krox20	using	EphA4	antibodies	(red).	To	monitor	the	
electroporated	 side	 of	 the	 hindbrain,	 a	GFP	 expression	 vector	
was	 included	 in	 all	 the	 experiments	 (green).	 (I)	 Fluorescence	
intensities	 of	 EphA4	 were	 measured	 in	 A,	 C,	 E	 and	 G	 with	
MetaMorph	 software	 (see	 Materials	 and	 Methods).	 For	 this,	
regions	 of	 the	 same	 area	 in	 r3	 and	 r5	 were	 defined	 on	 both	










































overexpression	 of	 Nab	 and	 SUMO1,	 the	 SUMOylation	 defective	 mutant	 KR2	 was	 tested,	
showing	a	very	interesting	result	as	EphA4	expression	was	not	reduced	but	increased	in	the	
electroporated	side	 (Figure	R-15G,	15H	and	15I).	This	 result	 supports	a	dominant-negative	
effect	of	the	KR2	mutant	that	would	compete	with	wild	type	Nab	for	interacting	with	Krox20.	
Taking	 these	 results	 into	 consideration,	 we	 decided	 to	 further	 investigate	 the	 effects	 of	
electroporating	the	KR2	mutant.	Expression	analysis	of	 the	r4	marker	Hoxb1	 together	with	
EphA4	by	double	 in	situ	hybridization	showed	that	electroporation	of	 the	KR2	mutant	also	
resulted	 in	 reduced	 r4	 size	 (Figure	 R-16A	 and	 16B),	 possibly	 associated	 with	 aberrant	
expansion	of	r3	and/or	r5.	Finally,	we	analysed	the	effects	of	electroporating	the	KR2	mutant	
over	Krox20	expression,	as	it	is	described	to	be	self-regulated	in	a	positive	way	(Chomette,	D	






Figure	 R-16:	 Nab	 modification	 by	 SUMO1	
affects	 the	 expansion	 of	 r3	 and	 r5.	 (A)	 Flat	
mounts	 from	 the	hindbrain	 of	HH13-14	 chick	
embryos	 electroporated	 on	 the	 left	 side	 (*)	
with	 the	 Nab	 KR2	 expression	 construct.	
Embryos	 were	 harvested	 24h	 after	 electro-
poration	 and	 processed	 for	 in	 situ	
hybridization.	 Specific	 antisense	 RNA	 probes	
against	 EphA4	 (orange),	 Hoxb1	 and	 Krox20	
(purple)	were	utilised	 to	 analyse	 these	 genes	
expression	and	determine	the	extension	of	r4	
territory	(white	arrows).	(B)	The	size	of	r4	was	
measured	 as	 the	 extension	 of	 Hoxb1	
expression	 with	 ImageJ	 software	 and	 the	
intensity	of	Krox20	 expression	was	measured	
with	MetaMorph	software	(see	materials	and	
Methods).	 In	 both	 cases,	 signal	 values	 of	 the	
electroporated	sides	were	normalized	to	their	
control	 sides.	 Values	 are	means	 ±	 s.d.	 of	 5-8	

































	 With	 the	aim	of	 studying	whether	 the	SUMO	modification	pathway	 is	 implicated	 in	
neuronal	 development,	 we	 decided	 to	 analyse	 global	 SUMOylation	 and	 the	 expression	





	 As	 a	 first	 attempt	 to	 investigate	 the	 involvement	 of	 SUMOylation	 in	 neuronal	
differentiation	we	focused	on	studying	whether	the	process	involves	changes	in	the	levels	of	
SUMO	conjugation.	Thus,	we	evaluated	SUMO	conjugation	under	proliferation	and	neuronal	
differentiation	 conditions.	 We	 took	 advantage	 of	 the	 pluripotent	 P19	 cell	 line,	 a	 mouse	
teratocarcinoma	cell	line	easy	to	differentiate	into	neurons	by	treating	the	cells	with	retinoic	
acid	 (RA)	 (MacPherson,	 PA	 et	 al.,	 1997)	 (see	Materials	 and	Methods).	 After	 four	 days	 of	
treatment,	although	cells	have	not	achieved	terminal	differentiation,	they	have	reached	an	
interesting	 differentiating	 state,	 as	 the	 pluripotency	 marker	 Oct4	 is	 completely	
downregulated	 while	 the	 neuronal	 marker	 ßIII-tubulin	 starts	 to	 be	 abundantly	 expressed	
(Figure	 R-17A).	 In	 immunoblots,	 together	 with	 unconjugated	 (free)	 SUMO,	 SUMO1	 and	
SUMO2/3	 antibodies	 detected	 a	 smear	 of	 bands	 of	 high	 molecular	 mass	 (>70	 kDa)	
corresponding	 to	 SUMOylated	 proteins	 (Figure	 R-17A).	 In	 addition,	 Western	 blots	 with	
SUMO1	 antibodies	 showed	 that	 SUMOylated	 RanGAP1	 is	 clearly	 identified	 as	 a	 band	 of	
about	 80	 kDa.	 To	estimate	 SUMO	conjugation	we	decided	 to	 compare	 the	 amount	of	 the	














Figure	 R-17:	 Neuronal	 differentiation	 increases	 the	 free	
SUMO	 pool	 available	 in	 P19	 cells	 treated	 with	 RA.	 (A)	
Western	 blot	 to	 analyse	 the	 expression	 of	 the	 indicated	
proteins	 in	 P19	 cells	 under	 proliferative	 conditions	 or	 after	
4	days	 (d)	 of	 treatment	 with	 retinoic	 acid	 (RA).	 Protein	
extractions	were	performed	under	denaturing	conditions	to	
analyse	 SUMO	 conjugated	 products.	 For	 analysis	 of	 free	
SUMO,	denaturing	(SDS)	and	non-denaturing	(NP40)	protein	
extractions	 were	 performed	 (see	 Materials	 and	 Methods).	
SUMOylated	 RanGAP1	 can	 be	 observed	 in	 SUMO1	 blots	
(arrowhead).	 Oct4	 and	 ßIII-tubulin	 were	 visualized	 as	
controls	 of	 the	differentiation	process,	while	α-tubulin	was	
visualized	 as	 a	 loading	 control.	 20	μg	of	 total	 protein	were	
loaded	 per	 lane.	 (B)	 Quantification	 of	 the	 increase	 in	
expression	levels	of	the	indicated	proteins	from	proliferation	
to	 4d	 of	 RA	 treatment.	 Values	 are	 means	 from	 three	





















































































	 Interestingly,	 RA-treated	 cells	 exhibited	 a	 2-fold	 increase	 in	 both	 free	 SUMO1	 and	
SUMO2/3	pools	as	detected	under	denaturing	conditions,	while	no	changes	were	observed	
in	total	SUMO	as	measured	under	non-denaturing	conditions	(Figure	R-17).	Increase	in	free	
SUMO1	 mostly	 correlated	 with	 reduced	 levels	 of	 SUMOylated	 RanGAP1.	 By	 contrast,	
increase	 in	 free	 SUMO2/3	 correlated	 with	 a	 decrease	 in	 SUMO2/3	 high	 molecular	 mass	
bands.	Thus,	our	results	indicate	that	although	global	levels	of	SUMO1	and	SUMO2/3	seem	





	 As	a	next	step	 in	assigning	a	role	to	SUMO	modification	 in	neuronal	differentiation,	
we	decided	to	analyse	how	neurogenesis	proceeds	when	globally	altering	SUMOylation.	For	
that	purpose,	we	 chose	 to	 investigate	 the	effect	of	 SUMO	overexpression	on	 the	process.	






P19	 cells.	 P19	 cells	 were	 transfected	 with	 the	 indicated	 expression	 constructs	 for	 SUMO1	 and	
SUMO2	and,	 after	 cell	 harvesting,	denaturing	protein	extracts	were	analysed	by	western	blot	with	
SUMO1	 and	 SUMO2/3	 antibodies.	 An	 increase	 in	 SUMOylated	 products	 was	 detected	 when	 cells	






















	 A	well-established	model	 for	quantification	of	neurogenesis	 in	P19	cells	consists	on	
estimating	 the	proportion	of	 cells	 expressing	 the	neuronal	marker	ßIII-tubulin	among	cells	
transfected	with	expression	constructs	 for	 the	neurogenic	 factor	NeuroD2	and	 its	cofactor	
E12	 that	 lead	 to	 their	 differentiation	 (Farah,	 MH	 et	 al.,	 2000;	 Garcia-Gutierrez,	 P	 et	 al.,	
2012).	 To	 monitor	 transfected	 cells,	 a	 GFP	 expression	 vector	 was	 routinely	 included	 in	
transfections.	With	this	approach	and	as	shown	in	Figure	R-19,	we	could	observe	that	about	
61%	 of	 transfected	 cells	 expressed	 the	 neural	 specific	 marker	 ßIII-tubulin	 72	 h	 after	





Figure	 R-19:	 SUMO	 overexpression	 interferes	 with	 P19	 neuronal	 differentiation.	 (A)	
Immunofluorescence	experiments	on	P19	cells	 transfected	with	expression	constructs	 for	NeuroD2	
and	 its	 cofactor	 E12,	 to	 induce	 neuronal	 differentiation,	 or	with	 empty	 vector.	 SUMO1	or	 SUMO2	
expression	constructs	or	their	corresponding	empty	vector	were	also	cotransfected	when	indicated.	
A	 GFP	 expression	 vector	 was	 also	 included	 to	 monitorize	 transfected	 cells	 (green).	 ßIII-tubulin	 or	
Neurofilaments	 antibodies	 were	 used	 to	 analyse	 neuronal	 differentiation	 (red)	 and	 DNA	 was	
counterstained	with	DAPI	 (blue).	 Scale	bar	20	μm.	 (B)	Quantification	of	neuronal	differentiation	 in	
transfected	cells	was	obtained	as	the	percentage	of	transfected	cells	that	expressed	GFP	(green)	that	
also	expressed	the	analysed	neuron	specific	marker	(red).	Values	are	means	of	quantifications	from	




















































































the	 lumen	 in	 one	 side	 of	 the	 tube	 to	 perform	 gain-	 and	 loss-of-function	 experiments.	 As	
Figure	R-20	shows,	the	percentage	of	neurogenesis	can	also	be	estimated	in	this	model	by	
electroporating	 the	 progenitors	with	 a	 reporter	 construct	 and	 quantifying	 cells	 that,	 after	
migrating	 to	 the	ML,	 coexpress	 the	 reporter	 and	 neuron	 specific	 markers,	 over	 the	 total	
amount	of	cells	expressing	the	reporter.	
	
Figure	 R-20:	 Quantification	 of	 neuronal	
differentiation	 in	 the	 chick	 neural	 tube.	 Neural	
progenitors	 are	 electro-porated	 with	 a	 GFP	
expression	 vector	 (green).	 The	 neural	 progenitors	
eventually	start	to	migrate	from	the	ventricular	zone	
(VZ)	 to	 the	 mantle	 layer	 (ML)	 as	 indicated	 by	 the	
white	arrows,	while	they	get	differentiated	and	start	
ex-pressing	the	neural	marker	ßIII-tubulin	(red).	GFP	
positive	 cells	 that	 coexpress	 the	neural	marker	and	
localize	 to	 the	ML	 are	 quantified	 and	 relativized	 to	
the	 total	 amount	 of	 cells	 that	 express	 GFP	 in	 both	
compartments	 separated	 by	 a	 dashed	 line	 (VZ	 and	




	 In	 our	 case,	 electroporation	 of	 a	 GFP	 expression	 construct	 at	 the	 thoracic	 level	
indicated	 that	 30	 h	 after	 electroporation,	 about	 23%	 of	 transfected	 progenitors	migrated	
from	the	VZ	 to	 the	ML	and	expressed	 the	neuronal	marker	ßIII-tubulin	 (Figures	R-21A	and	
21B).	 Thus,	 23%	 of	 cells	 electroporated	 with	 the	 reporter	 naturally	 differentiated	 into	






instance	Neurogenin2,	was	 incorporated	 in	 the	 electroporation	 experiment,	 up	 to	 87%	 of	
reporter-positive	cells	got	differentiated.	We	then	analysed	the	effect	of	also	incorporating	
SUMO1	 or	 SUMO2	 expression	 constructs,	 and	 observed	 that	 in	 the	 presence	 of	





Figure	 R-21:	 SUMO	 overexpression	 interferes	 with	 neuronal	 differentiation	 in	 the	 chick	 neural	
tube.	(A)	The	neural	tube	of	chick	embryos	at	stage	HH17	was	electroporated	on	the	right	side	with	
empty	vector	or	an	expression	construct	for	Neurogenin2	(Ngn2)	to	induce	neurogenesis.	SUMO1	or	
SUMO2	 expression	 constructs	 or	 their	 corresponding	 empty	 vector	 were	 coelectroporated	 when	
indicated	and	a	GFP	expression	vector	was	also	included	to	monitorize	the	electroporated	side	of	the	
neural	 tube	 (green).	Neurogenesis	was	analysed	30h	after	electroporation	by	 immunofluorescence	
on	transverse	sections	of	the	neural	tube	using	antibodies	for	neuron	specific	markers	ßIII-tubulin	or	
Neurofilaments	(red).	DNA	was	counterstained	with	DAPI	(blue).	Electroporated	cells	that	expressed	
GFP	and	were	differentiating	 into	neurons	were	 identified	by	 localization	 to	 the	mantle	 layer	 (ML)	
and	expression	of	the	neuron	specific	markers.	Scale	bar	50	μm.	(B,	C)	Quantification	of	neurogenesis	






















































































investigate	whether	 SUMO	 overexpression	 in	 fact	 interferes	 with	 neuronal	 differentiation	
rather	than	simply	delaying	it,	we	also	analysed	effects	of	SUMO	overexpression	40	h	after	
electroporation.	Results	were	similar	to	those	obtained	at	30	h	(Figure	R-22),	supporting	an	









in	 Figure	 R-21.	 Neurogenesis	 was	 analysed	 40h	 after	 electroporation	 by	 immunofluorescence	 on	
transverse	 sections	 of	 the	 neural	 tube	 using	 ßIII-tubulin	 antibodies	 (red).	DNA	was	 counterstained	
with	DAPI	(blue).	Electroporated	cells	that	expressed	GFP	and	were	differentiating	into	neurons	were	
identified	 by	 localization	 to	 the	 mantle	 layer	 (ML)	 and	 expression	 of	 the	 neuron	 specific	 marker	
ßIII-tubulin.	Scale	bar	50	μm.	(B)	Quantification	of	neurogenesis	in	(A)	obtained	as	the	percentage	of	
GFP	positive	cells	(green)	that	have	migrated	from	the	proliferative	compartment	or	ventricular	zone	
(VZ)	 to	 the	differentiated	compartment	 (ML)	and	 that	express	ßIII-tubulin.	Values	are	means	±	 s.d.	
















































	 As	 the	 previous	 results	 showed	 that	 SUMOylation	 is	 altered	 during	 neuronal	













Figure	 R-23:	 RA	 treatment	 to	 induce	 neural	 differentiation	 of	 P19	 cells.	 P19	 cells	 are	 cultured	 in	
suspension	with	low	serum	and	RA	supplemented	medium	to	induce	the	initial	response	(1).	Cells	are	
grown	 in	 these	 conditions	 during	 four	 days	 (with	 RA	 replacement	 at	 day	 2)	 in	 which	 they	 form	
embryoid	 bodies	 and	 the	 initial	 differentiation	 takes	 place	 (2).	 Finally,	 P19	 cells	 are	 disaggregated	
































Figure	 R-24:	 Expression	 analysis	 of	 PIAS	 ligases	 and	 basic	 components	 of	 the	 SUMOylation	
machinery	 during	 P19	 neuronal	 differentiation	 with	 RA	 treatment.	 Real-Time	 PCR	 determined	
relative	 expression	 levels	 of	 the	 indicated	 genes.	 P19	 cells	 were	 harvested	 after	 the	 following	
conditions:	2	or	4	days	(d)	of	RA	treatment	in	suspension,	and	4	days	of	RA	treatment	in	suspension	
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4.2.4 The	 SUMO	 proteases	 Senp5	 and	 Senp7	 are	 upregulated	 during	 neuronal	
differentiation.	
	
	 We	 continued	 our	 gene	 expression	 analysis	 by	 looking	 at	 genes	 coding	 for	 SUMO	
proteases.	For	that	purpose,	we	investigated	the	six	members	of	the	SENP	family	(Senp1-3,	
5-7)	and	one	member	of	the	more	recently	described	DeSI	family	of	proteases,	Desi1	(Shin,	
EJ	 et	 al.,	 2012).	 Results	 indicated	 that	 expression	 levels	 of	 most	 of	 the	 analysed	 genes	
remained	quite	unaltered	along	the	differentiation	protocol,	with	the	surprising	exception	of	
Senp5	 and	Senp7.	Senp5	expression	progressively	augmented	 to	 reach	a	9-fold	 increase	at	
day	7	(Figure	R-25A).	In	contrast,	Senp7	levels	picked	at	day	4,	displaying	a	16-fold	increase	if	
compared	 with	 day	 0,	 and	 dropping	 slightly	 at	 day	 7	 (Figure	 R-25A).	 As	 Senp7	 gene	
expression	 displayed	 the	 highest	 variation	 following	 induction	 of	 neuronal	 differentiation,	
we	chose	to	further	investigate	it.	
	 We	 first	 studied	 whether	 increased	 gene	 expression	 correlated	 with	 increased	
protein	levels.	Western	blot	experiments	demonstrated	a	4.3-	fold	increase	in	protein	levels	




also	 when	 applying	 the	 neuronal	 differentiation	 protocol	 involving	 transfection	 of	 the	
neurogenic	 factor	 NeuroD2	 and	 its	 cofactor	 E12	 (Figure	 R-26).	 As	 an	 additional	 control,	
Senp3	 levels	were	 also	 checked	 and	no	differences	were	observed	between	days	 0	 and	 4	

















Figure	 R-25:	 Senp5	 and	 Senp7	 are	 upregulated	 during	 P19	 neuronal	 differentiation	 by	 RA	
treatment.	(A)	Real-Time	PCR	determined	relative	expression	levels	of	the	indicated	SUMO	proteases	
genes.	 P19	 cells	 were	 treated	 as	 previously	 indicated	 in	 Figure	 R-24.	 Expression	 levels	 were	
normalized	 to	 the	 levels	 at	 0	 days.	 Values	 are	means	 ±	 s.d.	 of	 three	 independent	 experiments	 in	
duplicate.	Statistical	significance	of	changes	in	gene	expression	was	analysed	by	the	Student's	t-test,	
and	 P-values	 for	 Senp5	 and	 Senp7	 upregulation	 were	 indicated.	 (B)	 Protein	 levels	 of	 Senp7	 were	
analysed	by	Western	blot	along	 the	differentiation	protocol	 applied	 in	 (A).	 Levels	of	Oct4	and	ßIII-
tubulin	 were	 determined	 as	 controls	 for	 neurogenesis.	 Blots	 for	 α-tubulin	 are	 also	 included	 as	 a	
loading	control.	20	μg	of	total	protein	were	loaded	per	 lane.	(C)	Relative	levels	of	Senp7	protein	as	
quantified	in	(B).	Protein	levels	were	normalized	to	the	level	at	0	days.	Values	are	means	±	s.d.	from	
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Figure	 R-26:	 Both	 RA	 treatment	 and	 over-
expression	 of	 neurogenic	 factor	 NeuroD2	
upregulate	 Senp7.	 	 Senp7,	 Senp3,	 Oct4,	 ßIII-
tubulin	 and	 α-tubulin	 protein	 levels	 were	
analysed	 by	Western	 blot	 in	 P19	 cells	 treated	








(shRNA)	 molecules	 in	 order	 to	 knockdown	 Senp7	 by	 RNA	 interference	 in	 P19	 cells.	 We	
generated	two	different	molecules	targeting	Senp7	and	both	performed	equally	in	knocking	
down	the	SUMO	protease	and	in	the	first	experiments	of	the	functional	characterization,	so	
results	 presented	 correspond	 to	 one	 of	 these	 molecules	 (shRNA	 mouse	 Senp7#1)	 (see	
Table	M-4).	In	P19	cells	under	proliferation,	Senp7	showed	basal	expression	levels	that	were	
lessened	to	a	33%	in	cells	transfected	with	the	shRNA	molecule	against	Senp7,	compared	to	
a	 control	 shRNA	 (Figures	R-27A	 and	 27C).	 As	 Senp7	 upregulation	 was	 detected	 after	
induction	 of	 neuronal	 differentiation,	 we	 decided	 to	 also	 check	 Senp7	 knocking	 down	 by	
cotransfection	 of	 the	 shRNA	 against	 Senp7	 in	 addition	 to	NeuroD2	 and	 E12.	 It	was	 under	
these	 neuronal	 differentiation	 conditions	 that	 a	 10-fold	 reduction	 in	 the	 SUMO	 protease	
expression	was	 observed	when	 compared	 to	 cotransfection	 of	 a	 Control	 shRNA	 construct	
and	the	neurogenic	factors	(Figures	R-27B	and	27D).	We	then	turned	to	analyse	the	possible	




























Figure	 R-27:	 Senp7	 knockdown	 during	 P19	 neuronal	 differentiation.	 (A)	 P19	 cells	 growing	 under	
proliferative	 conditions	 were	 transfected	 with	 either	 control	 shRNA	 (shC)	 or	 Senp7	 shRNA	 (sh7)	
expression	 constructs,	 and	 Senp7	 protein	 levels	 were	 analysed	 72h	 after	 transfection	 by	 western	






in	 (C)	were	normalized	 to	 the	 levels	of	 cells	 transfected	with	 the	 control	 shRNA	construct.	 Protein	
levels	in	(D)	were	normalized	to	the	levels	of	cells	transfected	with	empty	vectors.	Values	are	means	



























































Figure	 R-28:	 Senp7	 knockdown	 prevents	 deconjugation	 of	 SUMO2/3	 during	 P19	 neuronal	
differentiation.	Effect	of	Senp7	 shRNA	compared	 to	control	 shRNA	on	SUMO1	(left)	and	SUMO2/3	
(right)	 conjugation	 was	 verified	 by	 Western	 blot	 of	 denaturing	 protein	 extracts	 from	 P19	 cells	






to	 61%	 of	 transfected	 cells	 and	 interestingly	 dropped	 to	 27%	 when	 cotransfecting	 an	
expression	 construct	 for	 Senp7	 shRNA,	 while	 no	 significant	 effects	 were	 observed	 when	
using	a	Control	shRNA	expression	construct	(58%	of	neurogenesis)	(Figures	R-29A	and	29B).	
We	 also	 developed	 two	 different	 molecules	 targeting	 the	 chick	 Senp7	 sequence.	 Both	
molecules	 also	 performed	 equally	 in	 the	 loss-of-function	 analysis	 so	 results	 presented	
correspond	to	one	of	these	molecules	(shRNA	chick	Senp7#1)	(see	Table	M-4).	The	obtained	
results	 indicated	 that	 when	 electroporating	 chick	 Senp7	 shRNA,	 Neurogenin2-promoted	
differentiation	was	significantly	impaired,	while	a	Control	shRNA	molecule	had	no	effect.	The	
use	of	Senp7	shRNA	lessened	neurogenesis	to	40%,	while	almost	80%	was	observed	in	the	
presence	 of	 Control	 shRNA	 (Figures	 R-29C	 and	 29D).	 Thus,	 induced	 neurogenesis	 by	




































control	 shRNA	 (sh	 Control)	molecules,	 or	 the	 corresponding	 empty	 vector.	 Transfected	 cells	 were	
monitored	by	expression	of	a	GFP	expression	vector	 (green)	and	those	differentiating	 into	neurons	
were	 revealed	 by	 expression	 of	 the	 neuron	 specific	 marker	 ßIII-tubulin	 (red).	 DNA	 was	
counterstained	with	DAPI	(blue).	Scale	bar	20	μm.	(B)	Quantification	of	the	%	of	neurogenesis	of	the	
analysis	in	(A)	as	the	proportion	of	GFP	positive	cells	(green)	expressing	the	ßIII-tubulin	marker	(red).	
Values	 are	 means±	 s.d.	 obtained	 by	 counting	 cells	 from	 a	 total	 of	 30	 areas	 of	 3	 independent	




with	 expression	 constructs	 for	 Senp7	 shRNA,	 control	 shRNA	 or	 the	 corresponding	 empty	 vector.	
Neurogenesis	was	evaluated	by	 immunofluorescence	after	30h	on	transverse	sections	of	the	spinal	





































































































to	 analyse	 reporter	 activation	of	 a	GFP	 construct	 driven	by	 the	 5ʹ	 upstream	 region	of	 the	
Senp7	gene,	encompassing	the	Senp7	promoter	(S7p).	To	this	end,	we	compared	expression	
of	 this	 construct	 (S7p-GFP)	 with	 that	 of	 a	 GFP	 driven	 by	 the	 constitutive	 promoter	 CMV	
(CMV-GFP)	 in	 electroporation	 experiments	 on	 the	 chick	 neural	 tube.	We	 initially	 used	 the	
human	 S7p	 sequence,	 as	 it	 was	 available	 in	 our	 laboratory.	 In	 all	 the	 experiments,	
transfected	 cells	 were	monitored	 by	 expression	 of	 the	mCherry	 protein	 driven	 by	 a	 CMV	
























	 As	 illustrated	 in	 Figure	R-31A,	 while	 virtually	 all	 cells	 expressing	 mCherry	 also	
expressed	GFP	when	expression	of	 this	 last	was	driven	by	 the	CMV	promoter,	very	 few	of	




results	 may	 also	 indicate	 that	 the	 Senp7	 promoter	 is	 early	 and	 transiently	 activated	 in	
differentiating	 neurons	 so	 that	 at	 the	 time	 of	 the	 analysis	 the	 reporter	 starts	 to	 be	
downregulated.	 To	 shed	 light	 on	 the	 way	 that	 Senp7	 promoter	 is	 activated,	 we	 analysed	
reporter	activation	following	 induction	of	neurogenesis.	We	tested	Neurogenin2	as	well	as	
NeuroM,	 as	 both	 are	 early	 neurogenic	 factors	 (Bertrand,	N	 et	 al.,	 2002;	 Roztocil,	 T	 et	 al.,	
1997).	 Twenty	 hours	 after	 coelectroporation	 of	 the	 GFP	 reporter	 and	 the	 indicated	
constructs	in	Figure	R-31C,	very	few	of	the	mCherry	positive	cells	displayed	GFP	even	in	the	
presence	 of	 neurogenic	 factors.	 However,	 10	 h	 after	 electroporation,	 a	 high	 number	 of	
mCherry	positive	cells	were	also	GFP	positive	(Figure	R-31C)	when	expression	constructs	for	
neurogenic	factors	were	coelectroporated,	confirming	neurogenesis-mediated	activation	of	
the	 reporter	 and	 pointing	 to	 its	 early	 and	 transient	 expression	 in	 differentiating	 neurons.	
Although	most	mCherry	positive	 cells	 did	not	 exhibit	GFP	20	h	 after	 electroporation,	 they	
massively	 localized	 to	 the	pial	 surface,	 indicative	of	neuronal	differentiation	driven	by	 the	
neurogenic	 factors.	 We	 confirmed	 former	 results	 using	 the	 chick	 Senp7	 promoter	
(Figure	R-32).	 Hence,	 under	 naturally	 occurring	 neurogenesis,	 a	 reduced	 number	 of	
electroporated	 neuronal	 progenitors	 activate	 the	 S7P-GFP	 reporter	 10	 or	 20	 h	 after	
electroporation.	 However,	 when	 inducing	 neurogenesis,	 very	 early	 (10	 h	 after	
electroporation)	 and	massive	 activation	 of	 the	 reporter	was	 observed,	 to	 be	 switched	 off	















Figure	 R-31:	 human	 Senp7	 promoter	 is	 early	 and	 transiently	 activated	 in	 neurogenesis.	 (A)	 The	
neural	tube	of	chick	embryos	at	stage	HH17	was	electroporated	on	the	right	side	with	the	indicated	




ßIII-tubulin	 (red).	 (C)	 Activation	 of	 the	 S7p-GFP	 reporter	 construct	 (green)	 was	 analysed	 under	
induced	 neurogenesis,	 10	 and	 20h	 after	 coelectroporation	 with	 expression	 constructs	 for	 the	
neurogenic	factors	NeuroM	or	Neurogenin2	(Ngn2),	as	 indicated.	The	corresponding	empty	vectors	
were	 electroporated	 as	 a	 control	 of	 natural-occurring	 neurogenesis	 and	 analysed	 10	 h	 after	
electroporation.	A	CMV-Cherry	expression	vector	was	included	in	all	the	experiments	to	monitor	the	









































than	 the	 human	 promoter	 in	 the	
chick	 neural	 tube.	 (A)	 The	 neural	
tube	 of	 chick	 embryos	 at	 stage	
HH17	 was	 electroporated	 as	
previously	 shown	 in	 Figure	 R-31A.	
A	GFP	reporter	under	the	control	of	
the	 promoter	 region	 of	 chicken	
Senp7	 gene	 (chS7p-GFP)	 was	 used	
in	this	experiment	instead	of	the	human	Senp7	reporter.	Reporter	activation	was	compared	20h	after	
electroporation	by	 immunofluores-cence,	 as	 previously	 indicated.	A	 CMV-Cherry	 expression	 vector	
was	included	in	both	experiments	to	monitor	the	electroporated	cells	(red).	DNA	was	counterstained	
with	 DAPI	 (blue).	 (B)	 Activation	 of	 the	 chS7p-GFP	 reporter	 construct	 (green)	 was	 analysed	 under	
induced	 neurogenesis,	 10	 and	 20h	 after	 coelectroporation	 with	 an	 expression	 construct	 for	 the	
neurogenic	 factor	Neurogenin2	 (Ngn2)	or	 its	 empty	 vector,	 as	previously	 shown	 in	 Figure	R-31C.	A	























and	neuronal	 differentiation.	 Tanking	 into	 consideration	 these	 results	 and	 the	 fact	 that	 in	
this	work	we	have	already	 focused	on	 the	 implication	of	 the	SUMO	modification	pathway	
itself	 in	the	process	of	neuronal	differentiation,	we	wanted	to	take	a	further	step	studying	
target	proteins	that	change	their	SUMOylation	state	during	this	process.	For	this	purpose,	a	
SILAC	 based	 proteomic	 analysis	 comparing	 the	 SUMO	 proteome	 of	 proliferative	 and	
differentiating	 P19	 cells	 was	 envisaged,	 establishing	 a	 collaboration	 with	 the	 group	 of	







	 A	 SILAC	 experiment	 requires	 very	 specialized	 conditions	 of	 cell	 culture,	 including	
special	medium	without	Arginine	and	Lysine,	 the	use	of	dialyzed	serum	and	the	culture	of	
cells	with	labelled	Arg	and	Lys.	The	classic	medium	(minimum	essential	medium	Eagle	with	















	 After	a	number	of	 cell	passages,	 cells	exhibited	a	normal	 shape	and	morphology	 in	
the	 three	 tested	 conditions	 and	 only	 a	 slightly	 higher	 growing	 ratio	 was	 observed	 in	 the	
condition	3	when	compared	to	condition	1.	
	 As	this	work	is	based	in	the	comparison	of	the	SUMO	proteome	in	proliferating	and	
differentiating	conditions,	 it	was	mandatory	 to	 test	whether	P19	cells	 cultured	 in	 the	new	
growing	conditions	with	DMEM	were	able	 to	undergo	proper	neuronal	differentiation.	For	
this	 purpose,	 we	 compared	 the	 expression	 of	 different	 markers	 in	 proliferation	 and	 at	
distinct	times	during	the	differentiation	protocol	with	RA	using	the	new	culturing	media.	
As	shown	 in	Figure	R-33,	by	western-blot	we	could	see	how	the	pluripotency	marker	Oct4	
was	 downregulated	 after	 2d	 of	 RA	 treatment,	while	 the	 expression	 of	 the	 neural	 specific	





Figure	 R-33:	 P19	 cells	 differentiate	 into	 neurons	 when	 treated	 with	 RA	 in	 culture	 media	
appropriate	for	SILAC	experiments.	Analysis	by	Western	blot	of	P19	cells	neural	differentiation	when	
cultured	 in	 three	different	 growing	 conditions	 as	 indicated	on	 top	of	 each	blot	 (see	Materials	 and	
Methods).	 P19	 cells	 were	 then	 differentiated	 with	 RA	 and	 harvested	 after	 2	 or	 4	 days	 (d)	 of	 RA	








cofactor	 E12.	By	 immunofluorescence	experiments	 (Figure	R-34),	we	 could	monitorize	 the	
expression	of	ßIII-tubulin	in	properly	differentiated	P19	cells.	














constructs	 for	 NeuroD2	 and	 its	 cofactor	 E12,	 to	 induce	 neuronal	 differentiation.	 ßIII-tubulin	
































be	 obtained	 in	 a	 single	 experiment	 comparing	 two	 different	 labelled	 conditions.	 These	
considerations	 made	 us	 to	 work	 with	 a	 high	 number	 of	 cells	 in	 the	 final	 large-scale	










non-labelled	 amino	acids	 (light	AA)	 in	proliferating	 (Prolif.)	 and	differentiating	 (Dif.	 RA)	 conditions,	
respectively.	 In	 the	 second	 set	 (Exp.	 2),	 light	 AA	 and	 heavy	 labelled	 AA	 were	 employed	 in	
proliferation	 and	 differentiation	 conditions,	 respectively.	 After	 harvesting,	 lysing	 and	 mixing	
proliferative	 and	 differentiating	 cells	 from	 each	 experiment	 as	 indicated,	 three	 SUMO	 IPs	 per	
























4.3.2 SUMO	 immunoprecipitation	 and	 peptide	 elution	 effectively	 enriches	 P19	 cell	
extracts	with	endogenously	SUMOylated	proteins.	
	
	 To	 immunoprecipitate	 SUMO	 conjugates,	 the	 use	 of	 an	 affinity	 matrix	 coupled	 to	
SUMO	 antibodies	 is	 needed.	 In	 this	 work,	 SUMO1	 and	 two	 different	 batches	 of	 SUMO2	
antibodies	were	obtained	from	hybridoma	21C7	and	8A2	cells	 (The	Developmental	Studies	
Hybridoma	Bank	at	the	University	of	Iowa),	respectively,	to	be	coupled	to	the	agarose	beads	
that	 form	 the	 affinity	matrix.	 Control	 beads	 were	 also	 prepared	 with	 commercial	 normal	
mouse	 IgG.	We	 checked	 the	 coupling	 efficiency	 comparing	 the	 release	 of	 heavy	 and	 light	









staining	 of	 agarose	 beads	
coupled	 to	 SUMO1	 and	
two	 batches	 of	 SUMO2	
antibodies	 as	 well	 as	
control	 IgG.	 The	 beads	
incubated	with	each	SUMO	







the	 control	 samples	 were	
subsequently	 incubated	 in	
the	 presence	 of	 SDS	 at	
37°	C	 or	 boiled	 with	
SDS	+	DTT	 at	 96°	 C	 and	
separated	 by	 SDS-PAGE.	
Coomassie	 staining	 shows	
how	 denatured	 light	 and	
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and	 supernatants,	 indicating	 the	 successful	 binding	 of	 antibodies	 to	 the	 beads.	 When	
analysing	 the	 crosslinked	 samples,	 no	 antibody	 chains	were	 observed	 in	 the	 supernatants	
and	 only	 a	 small	 fraction	 appeared	 in	 the	 beads,	 indicating	 that,	 though	 being	 incubated	
with	DTT,	 crosslinking	was	 efficient	 and	most	 of	 the	 antibodies	 remained	 attached	 to	 the	
beads.	These	satisfactory	results	were	obtained	for	control	and	SUMO1	beads,	as	well	as	for	
the	second	batch	of	SUMO2	beads.	
	 After	harvesting	all	 cellular	samples	of	both	sets	of	SILAC	experiments	according	 to	
the	workflow	chart	 in	 Figure	R-35	 (see	Materials	 and	Methods),	 cell	 lysates	were	made	 in	
radioimmunoprecipitation	 assay	 (RIPA)	 conditions	 according	 to	 the	 protocol	 detailed	 in	
(Barysch	et	al.	2014).	For	each	set	of	experiments	the	protein	concentration	was	determined	
for	 proliferative	 and	 differentiating	 samples,	 both	 samples	 of	 each	 set	were	mixed	 to	 the	
same	 protein	 amount	 and	 inputs	 were	 taken.	 Once	 again,	 amino	 acid	 incorporation	
efficiency	was	determined	 to	be	98%	and	 the	Arg	 to	Pro	 conversion	was	minimum.	Then,	
immunoprecipitation	(IP)	of	SUMO1,	SUMO2	and	control	IgG	was	performed	for	each	set	of	
lysates	 using	 the	 previously	 synthesized	 beads	 and,	 after	 elution	 with	 specific	 peptides	
corresponding	 to	 the	 epitopes	 recognized	 by	 the	 antibodies,	 SUMO	 conjugates	 were	
efficiently	 purified	 as	 shown	 by	 Western	 blot	 (Figure	 R-37).	 Finally,	 for	 each	 set	 of	
experiments,	 inputs	 and	 eluted	 IgG,	 SUMO1	 and	 SUMO2	 samples	 were	 sent	 to	 the	 Core	
Facility	 for	Mass	 Spectrometry	 and	 Proteomics	 (CFMP)	 at	 the	 ZMBH	 for	MS	 analysis	 and	































































































































4.3.3 Several	 proteins	 are	 identified	 as	 differentially	 SUMOylated	 targets	 between	
proliferative	and	differentiating	P19	cells.	
	
	 Mass	 spectrometry	 data	 analysis	 was	 conducted	 in	 the	 group	 of	 Prof.	 Frauke	
Melchior,	at	the	ZMBH	in	Heidelberg.	For	this,	data	of	identified	Razor	and	unique	peptides,	
as	 well	 as	 intensities,	 were	 considered	 from	 inputs	 and	 from	 IgG-IP,	 SUMO1-IP	 and	
SUMO2-IP	in	both	sets	of	experiments.	
	 After	 a	 first	 statistical	 analysis	 of	 the	 data,	 only	 2240	 proteins	 from	 the	 total	
identified	 were	 considered	 as	 true	 SUMO	 targets	 (see	 Apendix).	 Then,	 ratios	 for	 each	
light/heavy	 labelling	 intensities	 from	 SUMO1-IP	 and	 SUMO2-IP	 fractions	were	 considered.	
Targets	 that	 showed	 inverse	 ratios	 between	 both	 experiments	 for	 at	 least	 one	 of	 the	
SUMO-IP	 fractions	 (either	 SUMO1-IP	 or	 SUMO2-IP)	 were	 considered	 as	 SILAC	 candidates,	
including	in	this	category	a	total	of	318	proteins	(Figure	R-38).	These	ratio	changes	could	be	
essentially	 due	 to	 a	 remarkable	 change	 in	 the	 SUMOylation	 state	 of	 target	 proteins,	 but	
changes	could	also	be	due	to	a	significant	alteration	of	 the	 target	expression	 levels	during	
the	 differentiation	 process.	 To	 look	 for	 proteins	 that	 adjust	 to	 this	 first	 option,	 a	 further	
selection	step	was	necessary,	following	these	criteria:	
	









or	 SUMO2-IP.	 In	 the	 absence	 of	 one	 of	 the	 inputs	 data,	 both	 IgG-IP	 ratios	 were	











that,	 at	 least,	 one	of	 the	 ratios	 is	 due	 to	 real	 changes	 in	 their	 SUMOylation	 levels,	
assuming	that	the	other	SUMO-IP	may	be	considered	as	a	control.	
	









modification	or	 to	great	differences	 in	 their	expression	 levels,	 are	 represented	 (SUMO	SILAC;	 left).	
Numbers	of	proteins	modified	by	SUMO1,	SUMO2/3	or	both	paralogs,	are	indicated	above.	The	total	
amount	 of	 proteins	 considered	 in	 this	 case	 is	 indicated	below.	 Target	 proteins	whose	 SILAC	 signal	
only	changed	due	 to	differential	SUMO	modification	but	are	similarly	expressed	 in	both	conditions	
are	 also	 represented	 (SUMO	 relative;	 right).	 Again,	 numbers	 of	 proteins	 modified	 by	 SUMO1,	






































IgG Input S1 	S2 IgG Input S1 S2 IgG Input S1 S2 IgG Input S1 S2
Ftl1 Ferritin	light	chain	1	and	2 3 4 16 3 6 8 15 2 4,33 3,00 9,49 1,93 0,13 0,12 0,05 NaN
Tet1 Methylcytosine	dioxygenase	TET1 0 0 11 11 0 0 19 5 NaN NaN 8,12 3,10 NaN NaN 0,14 0,22
Pml Protein	PML 0 3 22 27 4 1 19 25 NaN 2,68 7,95 6,38 0,34 NaN 0,22 0,27
Morc3 Microrchidia	family	CW-type	zinc-finger	3	 10 5 43 50 9 3 41 45 3,04 1,82 4,71 3,35 0,65 0,61 0,25 0,45
Sall2 Sal-like	protein	2 0 5 8 7 1 5 5 5 NaN 1,52 3,32 2,59 NaN 0,62 0,26 0,46
Zfp518b Zinc	finger	protein	518B 1 0 7 12 0 0 9 8 NaN NaN 3,01 11,22 NaN NaN 0,38 0,14
Nacc1 Nucleus	accumbens-associated	protein	1 0 4 10 9 1 1 6 8 NaN 0,93 1,92 1,04 1,59 NaN 0,47 1,12
Gon4l GON-4-like	protein 0 0 10 13 0 1 17 8 NaN NaN 1,05 0,40 NaN NaN 1,38 5,67
Kctd1 BTB/POZ	domain-containing	protein	KCTD1 0 1 8 11 1 0 9 16 NaN NaN 0,57 0,27 NaN NaN 1,84 4,30
Kctd15 BTB/POZ	domain-containing	protein	KCTD15 0 2 3 8 2 0 5 11 NaN NaN 0,48 0,08 NaN NaN 4,06 17,65
Trim24 Transcription	intermediary	factor	1-alpha 2 3 25 30 4 1 24 29 NaN NaN 0,47 0,20 9,23 NaN 2,24 5,68
Ncbp2 Nuclear	cap-binding	protein	subunit	2 0 2 4 0 1 3 3 1 NaN 1,49 0,42 NaN NaN 0,69 2,48 NaN
Cotl1 Coactosin-like	protein 0 4 7 0 1 7 3 0 NaN 0,60 0,19 NaN NaN 2,01 4,53 NaN
Nrip1 Nuclear	receptor-interacting	protein	1 0 0 12 21 1 0 9 25 NaN NaN 0,18 0,16 NaN NaN 2,83 9,44
SUMO1	SILAC	relative
Razor	+	unique	peptides Heavy/Light	labelling	ratios











IgG Input S1 	S2 IgG Input S1 S2 IgG Input S1 S2 IgG Input S1 S2
Tcof1 Treacle	protein 3 12 14 17 8 17 13 20 8,77 3,83 5,19 7,94 0,27 0,29 0,14 0,11
Nolc1 Nucleolar	and	coiled-	body	phosphoprotein	1 1 16 7 7 8 17 9 8 NaN 1,86 3,42 4,05 0,52 0,54 0,30 0,28




0 6 1 4 0 5 1 4 NaN 1,52 NaN 3,90 NaN 0,79 0,36 0,31
Nop58 Nucleolar	protein	58 8 19 26 33 14 25 26 27 1,53 1,38 2,15 3,78 0,69 1,00 0,49 0,30




0 3 13 17 0 2 13 8 NaN 0,85 1,16 1,78 NaN NaN 0,95 0,47
H2afz Histone	H2A,	V	and	Z 1 4 4 4 3 4 4 4 NaN 0,45 0,59 0,91 1,86 2,08 1,67 1,01
Nup214 Nuclear	pore	complex	protein	Nup214 0 20 17 17 1 22 17 19 NaN 1,17 0,92 0,41 NaN 0,86 1,93 3,60
Trim33 E3	ubiquitin-protein	ligase	TRIM33 2 7 25 26 2 4 25 24 NaN 0,92 0,85 0,28 NaN 1,24 1,29 4,17
Dnajc9 DnaJ	homolog	subfamily	C	member	9 1 11 0 3 1 2 3 5 NaN 0,43 NaN 0,20 NaN 1,83 1,87 17,43
Sec22b Vesicle-trafficking	protein	SEC22b 1 6 5 9 4 1 5 7 NaN 0,35 0,54 0,17 1,56 NaN 1,60 13,02
Etv6 Transcription	factor	ETV6 0 2 2 7 0 0 1 8 NaN 0,45 NaN 0,15 NaN NaN NaN 10,25
Nxn Nucleoredoxin 3 14 12 7 6 6 12 10 NaN 0,08 0,21 0,09 7,11 6,43 4,20 49,20





Utf1 1 11 0,13 0,15 0,05
SUMO2	SILAC	relative
NaN 13,92 7,84 94,62 0,11
Heavy/Light	labelling	ratios











IgG Input S1 	S2 IgG Input S1 S2 IgG Input S1 S2 IgG Input S1 S2












0 0 8 7 0 2 7 12 NaN NaN 3,83 3,70 NaN 0,71 0,33 0,22
Atrx Transcriptional	regulator	ATRX 15 15 48 55 3 11 45 36 3,54 0,83 2,93 2,77 0,67 1,09 0,32 0,39
Incenp Inner	centromere	protein 0 2 3 3 0 2 4 4 NaN 0,85 2,51 5,66 NaN 0,84 0,27 0,20
Suz12 Polycomb	protein	Suz12 1 1 8 12 0 7 10 17 NaN NaN 1,61 1,78 NaN 1,38 0,69 0,51
Gtf2i General	transcription	factor	II-I 2 39 48 73 21 35 43 60 NaN 0,60 0,33 0,15 3,50 1,65 3,79 6,93
Prox1 Prospero	homeobox	protein	1 0 0 16 14 5 0 9 20 NaN NaN 0,31 0,58 1,10 NaN 6,02 12,52
Ranbp2 E3	SUMO-protein	ligase	RanBP2 52 40 121 160 28 39 123 115 0,10 1,16 0,23 0,05 11,37 0,75 6,37 6,05
Razor	+	unique	peptides Heavy/Light	labelling	ratios














	 P19	 cells	 were	 grown	 under	 the	 same	 proliferative	 and	 differentiating	 conditions	
used	 in	 the	 previous	 large-scale	 experiment	 but	 without	 SILAC	 labelling,	 and	 SUMO1	 IPs	
following	 specific	 peptide	 elution	 was	 performed.	 Western	 blot	 analyses	 were	 initially	
restricted	to	samples	from	SUMO1	IPs	as	SUMO1	has	been	mostly	related	to	transcriptional	
regulation.	 The	 results	 showed	 how,	when	 looking	 at	 the	 inputs,	Morc3,	 Atrx	 and	 Trim24	
expression	 levels	remain	steady	during	the	differentiation	process	but,	when	analysing	the	





	 By	 contrast,	when	analysing	SUMOylation	of	 the	 ferritin	 light	 chain	 (FLC),	we	could	
not	observe	higher	molecular	mass	bands	corresponding	to	SUMO	modified	FLC,	and	only	a	
protein	 band	 of	 about	 21	 kDa	 was	 detected,	 either	 in	 both	 inputs	 and	 the	 IP	 of	 the	
proliferative	condition.	These	bands	correspond	to	the	unmodified	FLC	and	indicate	a	false	
positive	case	of	a	protein	that	 is	 recognized	 in	an	unspecific	way	by	the	SUMO	antibodies.	
We	 also	 wanted	 to	 analyse	 Irf2bp1	 since,	 although	 it	 did	 not	 mathematically	 fit	 to	 the	
restrictive	 criteria	 established	 to	 be	 considered	 as	 a	 relative	 SILAC	 candidate,	 MS	 data	
suggested	differential	SUMOylation	between	the	analysed	conditions.	Thus,	we	could	see	by	
Western	blot	how	Irf2bp1	is	more	efficiently	modified	by	SUMO1	in	differentiating	P19	cells,	
indicating	 that	 some	 proteins	 excluded	 from	 the	 group	 of	 relative	 SILAC	 candidates	 are	
indeed	differentially	SUMOylated	and	expressed	in	both	analysed	conditions	(Figure	R-39A).	
Protein	levels	of	Ubc9	were	also	analysed	as	a	negative	control	of	the	experiment,	as	almost	








Figure	 R-39:	 SUMOylation	 of	 targets	 identified	 by	 MS	 and	 validated	 in	 proliferative	 and	
differentiating	 P19	 cells.	 (A)	 P19	 cells	 grown	 in	 DMEM	 +	 FBS	 (see	Materials	 and	Methods)	 were	
harvested	 in	proliferative	conditions	 (0)	and	after	4d	of	RA	treatment	 (4).	After	denaturing	protein	
extraction	 and	 SUMO1	 IP,	 SUMOylation	 of	 Morc3,	 Atrx,	 Trim24	 and	 Irf2bp1	 was	 revealed	 with	
specific	antibodies	as	 indicated.	100%	of	eluates	 (Eluted)	and	0.02%	of	 inputs	 relative	 to	 the	 lysate	
volume	 were	 loaded.	 Blots	 show	 non-modified	 (blue	 arrows)	 and	 SUMO	modified	 (white	 arrows)	
forms	 of	 the	 analysed	 proteins.	 FLC	 (Ferritin	 light	 chain)	 (B)	 Whole	 protein	 extraction	 was	 also	












































Indeed,	 the	 presented	 results	 show	 how	modification	 by	 SUMO	has	 an	 impact	 at	 distinct	
levels	in	the	process	of	neuronal	differentiation	and	morphogenesis	of	the	nervous	system.	
The	work	here	described	has	shed	some	light	into	this	impact	and	connections,	but	further	





	 Taking	 into	 consideration	 the	 results	 obtained	 in	 this	work,	we	 have	 established	 a	
role	 for	 the	 transcription	 factor	 Krox20	 as	 an	 E3	 ligase	 during	 SUMOylation	 of	 its	
coregulators,	 the	 Nab	 proteins.	 Ligase	 activity	 of	 Krox20	 is	 based	 on	 a	 number	 of	
observations	that	also	account	for	the	establishment	of	a	regulatory	role	for	SUMO	during	
hindbrain	formation.	In	this	way,	overexpression	of	Krox20	under	limiting	SUMO	availability	
leads	 to	SUMOylation	of	 transfected	Nab	 (Figure	R-5),	which	 is	 in	accordance	with	Krox20	
being	 able	 to	 interact	 with	 Nab	 and	 Ubc9	 through	 different	 domains;	 the	 mentioned	
repressor	domain	R1	and	the	zinc	finger	domains,	respectively	(Figures	I-5	and	R-2).	 In	this	
















an	E3	 ligase.	To	our	knowledge,	 this	 constitutes	 the	 first	example	of	a	 transcription	 factor	
functioning	as	a	ligase	for	the	SUMOylation	of	its	own	coregulators.	
	 Our	 results	 support	 a	 role	 of	 Krox20	 in	 the	 local	 recruitment	 of	 Ubc9	 in	 its	
transcriptional	complex	 for	 the	SUMOylation	of	other	components,	as	has	been	shown	for	














	 Despite	 the	 numerous	 roles	 attributed	 to	 SUMO	 in	 eukaryotic	 cells,	 a	 function	 in	
transcriptional	 repression	 stands	 out	 (Garcia-Dominguez,	 M	 and	 Reyes,	 JC,	 2009).	
Accordingly,	the	results	presented	in	this	work	support	that	Nab	SUMOylation	accounts	for	
transcriptional	 repression.	 Regarding	 to	 this,	 it	 has	 been	 previously	 mentioned	 that	 the	
repressive	activity	of	Nab	is	partly	due	to	its	interaction	with	CHD4	through	the	CID	domain	
present	 in	 the	 C-terminus	 part	 of	 the	 protein	 (Srinivasan,	 R	 et	 al.,	 2006).	 In	 the	 same	
direction,	 the	 authors	 have	 reported	 that	 CHD4	 participates	 in	 the	 repressor	 activity	
associated	to	Nab2,	 though	 full	 repression	activity	 is	not	explained	by	 the	 interaction	with	




presented	 arise	 the	 possibility	 that	 SUMOylation	 is	 accounting	 for	 this	 repression	 activity.	
Indeed,	 the	 fact	 that	both	wild	 type	Nab2	and	 the	KR2	mutant	have	 the	 same	 interaction	






its	 own	 corepressors,	 the	 Nab	 proteins,	 has	 been	 proposed	 as	 a	 negative	 feedback	
regulatory	 loop	 that	would	account	 for	 the	control	of	 this	process	 (Mechta-Grigoriou,	F	 et	
al.,	2000).	Supporting	this	hypothesis,	interference	with	the	interaction	between	Krox20	and	
Nab	proteins	by	mutation	of	the	R1	domain	in	Krox20	and	the	NCD1	domain	in	Nab	proteins	
leads	 to	 delayed	 repression	 of	 Krox20	 target	 genes	 (Desmazieres,	 A	 et	 al.,	 2009;	
Desmazieres,	A	 et	al.,	 2008).	Our	gain-of-function	experiments	with	 the	Nab2	KR2	mutant	
show	 that	 interfering	 with	 Nab	 SUMOylation	 also	 leads	 to	 altered	 expression	 of	 Krox20	
target	 genes	 (Figure	 R-13	 and	 R-15)	 and	 to	 aberrant	 size	 of	 the	 implicated	 rhombomeres	
(Figure	R-16).	In	this	direction,	the	KR2	mutant	has	proven	to	be	really	useful	in	these	gain-
of-function	experiments,	as	it	shows	a	dominant-negative	effect	that	is	consistent	with	Nab	
SUMOylation	 limiting	 Krox20	 activity	 and	 the	 extension	 of	 rhombomeres	where	 Krox20	 is	
expressed,	 in	 agreement	 with	 the	 proposed	 role	 for	 Nab	 proteins	 (Figure	 D-1).	 However,	
experiments	 conducted	 in	mice	have	 shown	 that	 double	Nab	 knockout	 or	 knock-in	 of	 the	
I268F	mutation	in	Krox20	do	not	lead	to	major	defects	in	proper	patterning	of	the	hindbrain	
(Desmazieres,	 A	 et	 al.,	 2008;	 Le,	 N	 et	 al.,	 2005),	 pointing	 to	 the	 presence	 of	 redundant	
mechanisms	during	hindbrain	development	that	limit	the	expansion	of	territories	mediated	
by	krox20	expression	and	transcriptional	regulation.	
	 In	 conclusion,	 we	 have	 revealed	 an	 intriguing	 novel	 activity	 of	 the	 Krox20	
transcription	 factor,	 as	 a	 SUMO	 ligase	 for	 its	 coregulators,	 the	 Nab	 proteins.	 Nab	
SUMOylation	 affects	 Krox20	 transcriptional	 activity,	 establishing	 an	 additional	 loop	 in	 the	












repressor	effect	 that	SUMOylation	of	Nab	mediated	by	Krox20,	 together	with	Nab	 interaction	with	
CHD4,	displays	over	the	transcriptional	activity	of	Krox20.	Domains	in	yellow	correspond	to	Nab	and	
domains	in	green	correspond	to	Krox20.	The	black	arrow	indicates	transcriptional	activation	and	the	






	 The	 results	 previously	 shown	 in	 this	 work	 support	 a	 role	 for	 SUMO	 in	 regulating	
neural	 development.	 In	 further	 experiments	 we	 have	 investigated,	 though,	 whether	
SUMOylation	is	regulated	during	neurogenesis	and,	 if	so,	which	mechanisms	are	regulating	
it.	 Interestingly,	 we	 have	 observed	 that	 net	 SUMO	 deconjugation	 is	 detected	 during	
neurogenesis.	 To	 this	 point,	 in	 addition	 to	 this	 decrease	 in	 the	 levels	 of	 SUMOylated	

























and	 are	 in	 agreement	 with	 previous	 works	 reporting	 that	 overall	 SUMOylation	 decreases	
during	 brain	 development	 in	 rodents	 (Hasegawa,	 Y	 et	 al.,	 2014;	 Loriol,	 C	 et	 al.,	 2012;	
Watanabe,	M	et	al.,	2008).	Also	in	this	sense,	deSUMOy-lation	of	the	chromatin	associated	
factor	 Braf35,	 which	 is	 linked	 to	 neuronal	 differentiation,	 has	 been	 reported	 (Ceballos-
Chavez,	M	et	al.,	2012).	
	 The	 results	 in	 this	 work	 also	 show	 how	 SUMO	 overexpression	 leads	 to	 the	
impairment	 of	 neurogenesis	 in	 P19	 cells	 and	 chicken	 neural	 tube,	 also	 pointing	 to	 the	
association	 of	 enhanced	 SUMOylation	 with	 an	 undifferentiated	 state.	 Interestingly,	
overexpression	 of	 both	 SUMO1	 and	 SUMO2	 showed	 the	 same	 effect	 on	 neurogenesis	
(Figures	R-19	and	R-21),	raising	the	question	of	whether	they	work	independently	or	share	
overlapping	 sets	 of	 targets	 during	 the	 differentiation	 process.	 In	 this	 regard,	 though	
SUMOylation	 has	 been	 proven	 to	 be	 an	 essential	 mechanism	 in	 almost	 all	 eukaryotes,	
SUMO1	 has	 been	 reported	 not	 to	 be	 essential	 in	 mouse,	 suggesting	 that	 most	 functions	
could	 be	 fulfilled	 by	 SUMO2/3.	 However,	 its	 deletion	 can	 lead	 to	 severe	 phenotypes	 that	
seem	to	be	background-dependent	(Wang,	L	et	al.,	2014;	Zhang,	FP	et	al.,	2008).	We	have	






pathway	 during	 P19	 neuronal	 differentiation	 with	 RA	 has	 delivered	 interesting	 results.	
Through	 this	approach,	we	have	observed	how	upregulation	of	Senp	proteases	expression	
agrees	 with	 net	 SUMO	 deconjugation.	 Our	 results	 also	 indicate	 that	 several	 Pias	 ligases	
genes	 are	 upregulated	 during	 this	 process,	 suggesting	 de	 novo	 SUMOylation	 of	 certain	
targets	 (Figure	R-24).	This	possibility	has	to	be	taken	 into	account,	given	that	these	 ligases	
have	been	described	to	regulate	the	Wnt	signalling	pathway,	related	to	embryogenesis	and	
cell	 fate	 specification	 (reviewed	 in	 (Schmidt,	 D	 and	Muller,	 S,	 2003)).	 In	 addition	 to	 this,	
cellular	functions	of	Pias	proteins	out	of	their	SUMO	ligase	activity	have	also	been	described	
(Garcia-Dominguez,	M	et	al.,	2006)	and	the	numerous	post-translational	modifications	and	








	 In	 the	 previously	 mentioned	 expression	 analyses,	 we	 have	 observed	 an	 important	
upregulation	 of	 Senp5	 and	 Senp7	 proteases	 (Figure	 R-25	 and	 R-26),	 which	 have	 been	
associated	with	SUMO2/3	deconjugation	(Di	Bacco,	A	et	al.,	2006;	Gong,	L	and	Yeh,	ET,	2006;	
Shen,	LN	et	al.,	2009).	 In	this	regard,	as	expected,	our	results	show	that	the	knockdown	of	
Senp7	 impairs	 neurogenesis-mediated	 SUMO2/3	 deconjugation	 during	 neuronal	
differentiation	 of	 P19	 cells	 (Figure	 R-28),	 while	 has	 no	 appreciable	 effects	 on	 SUMO1	
conjugation	 levels.	However,	 the	 fact	 that	also	 free	SUMO1	 increases	during	neurogenesis	
suggests	 that	 all	 neurogenesis-mediated	 SUMO	 deconjugation	 cannot	 be	 exclusively	
attributed	 to	 these	proteases.	 Interestingly,	 our	 results	 indicate	 that,	while	 increased	 free	
SUMO2/3	 during	 neurogenesis	 correlates	 with	 a	 decrease	 of	 high	 molecular	 mass	
SUMOylated	products,	increased	free	SUMO1	seems	to	mostly	correlate	with	a	decrease	of	
SUMOylated	 RanGAP1	 levels	 (Figure	 R-28),	 though	 additional	 experiments	 should	 be	
performed	to	assess	a	specific	decrease	 in	 the	 levels	of	SUMOylated	RanGAP1	and	discard	
differentiation-induced	RanGAP1	degradation	(Figure	D-2).	However,	apart	from	the	impact	
that	lower	levels	of	SUMOylated	RanGAP1	may	have	on	neuronal	differentiation,	we	cannot	
rule	 out	 that	 SUMO1	 deconjugation	 from	 other	 targets	 has	 an	 important	 function	 in	 the	
process.	 Interestingly,	although	not	directly	related	to	neurogenesis,	 it	has	been	previously	
reported	that	the	SUMO1	associated	protease	Senp1	 is	necessary	for	normal	development	
of	 the	 mouse	 embryo	 (Sharma,	 P	 et	 al.,	 2013).	 To	 this	 point,	 we	 have	 not	 observed	
significant	 changes	 on	 the	 expression	 levels	 of	 Senp1	during	 P19	neuronal	 differentiation,	
but	this	does	not	exclude	that	Senp1	plays	a	role	in	the	process.	Differential	regulation	under	
proliferative	 and	 neuronal	 differentiation	 conditions	 of	 Senp	 proteins	 at	 different	 levels,	
other	 than	 the	 expression	 degree,	may	 account	 for	 the	 net	 balance	 of	 conjugated	 SUMO	
during	 neurogenesis.	 As	 an	 example,	 SENP3	 stabilization	 against	 proteasomal-mediated	
degradation	has	been	reported	following	oxidative	stress	(Huang,	C	et	al.,	2009;	Yan,	S	et	al.,	
2010).	We	have	demonstrated	an	increased	expression	of	Senp7	both	at	mRNA	and	protein	
levels	 following	 induction	of	 neuronal	 differentiation	 (Figures	 R25	 and	R26),	 and	 knocking	




differentiation	 (Figures	 R-29).	 A	 scaffolding	 function,	 essential	 for	 proper	 chromosome	
segregation	 and	 not	 directly	 related	 to	 its	 SUMO-specific	 protease	 activity,	 has	 been	
reported	for	Senp7	mediating	HP1	enrichment	at	pericentric	heterochromatin	(Maison,	C	et	
al.,	 2012;	 Romeo,	 K	 et	 al.,	 2015).	We	have	 not	 investigated	 Senp7	 enzymatic	 activity	 but,	
regarding	 this	 aspect,	 it	 is	 interesting	 to	 remark	 that	 neurogenesis-mediated	 increase	 of	






Figure	 D-2:	 General	 model	 for	 changes	 in	 protein	 SUMOylation	 during	 neuronal	 differentiation.	
Schematics	 showing	 how	 neuronal	 differentiation	 proceeds	 with	 SUMO1	 (S1)	 deconjugation	 from	
modified	targets,	being	mostly	appreciable	in	deSUMOylation	of	RanGAP1,	and	with	SUMO2/3	(S2/3)	
deconjugation	 from	modified	 targets	 (unidentified	 X	 and	 Y	 proteins).	 Lower	 levels	 of	 SUMOylated	




	 As	previously	mentioned,	 in	addition	 to	Senp7,	Senp5	 is	also	upregulated	 following	
induction	of	neurogenesis	 in	P19	cells.	At	 this	point,	 the	question	about	Senp5	and	Senp7	
redundancy	 of	 function	 or	 specificity	 of	 targets	 during	 this	 process	 arises.	 We	 have	
performed	 preliminary	 loss-of-function	 analyses	 that	 reveal	 less	 dramatic	 effects	 in	
neurogenesis	 in	 the	 absence	 of	 Senp5	 than	 those	 observed	 in	 the	 absence	 of	 Senp7	 (not	



















from	 acute	myeloid	 leukemia	 patients	 (Federzoni,	 EA	 et	 al.,	 2015).	 Thus,	 it	 is	 tentative	 to	
assign	a	role	to	a	subset	of	SUMO	proteases	in	the	onset	of	diverse	differentiation	processes.	
	 To	 further	 investigate	 the	 way	 in	 which	 Senp7	 expression	 is	 upregulated	 during	
neuronal	 differentiation,	 expression	 analysis	 of	 a	 GFP	 reporter	 driven	 by	 the	 Senp7	
5ʹ-upstream	 region	 encompassing	 its	 promoter	 has	 permitted	 us	 to	 monitor	 transient	
expression	of	the	reporter	upon	induction	of	neuronal	differentiation	in	the	neural	tube	of	
chick	embryos.	These	results,	together	with	Senp7	peaking	its	expression	at	day	4	of	the	RA	
treatment	 to	 differentiate	 P19	 cells	 (before	 cells	 extend	 dendritic	 and	 axonal	 processes)	
(Figure	R-25),	 point	 to	 a	 role	of	 Senp7	 at	 very	 early	 stages	of	 neurogenesis.	As	 previously	
mentioned	during	the	introduction	of	this	work,	Neurogenins	are	proneural	genes	placed	at	
the	earliest	stages	in	the	cascade	of	factors	involved	in	neurogenesis	(Ma,	Q	et	al.,	1999;	Ma,	





observed	 localization	 of	 reporter	 positive	 cells	 close	 to	 the	 SVZ,	 which	 may	 suggest	 that	
Senp7	 displays	 an	 expression	 pattern	 similar	 to	 that	 of	 NeuroM.	 However,	 neither	
Neurogenin2	nor	NeuroM	were	able	to	sustain	reporter	expression	over	the	time	when	used	
to	 induce	neurogenesis,	 indicating	that	the	promoter	sequence	 is	not	directly	regulated	by	
these	 factors	 (Figures	 R-31	 and	 R-32).	 Thus,	 other	 factors,	 transiently	 activated	 when	
triggering	 neurogenesis	 by	 overexpression	 of	Neurogenin2	 or	NeuroM	 in	 the	 neural	 tube,	
should	 account	 for	 early	 and	 transient	 activation	 of	 the	 reporter.	 When	 inducing	
neurogenesis	by	overexpression	of	neurogenic	factors,	virtually	all	transfected	cells	migrate	
into	 the	ML	 and	 end	 up	 localizing	 to	 the	most	 distal	 part	 from	 the	VZ.	 Accordingly,	 upon	
induction	 of	 neurogenesis	 following	 the	 electroporation	 of	 neurogenic	 factors,	 although	
reporter	was	switched	off	with	 time,	electroporated	cells	normally	migrated	 to	 the	ML,	as	
revealed	 by	 localization	 of	 cells	 expressing	 the	 CMV-mCherry	 construct	 that	 we	 used	 to	
monitorize	electroporated	cells	(Figure	R-31	and	R-32).	
	 In	 conclusion,	 this	 work	 describes	 for	 the	 first	 time	 that	 proper	 neuronal	





to	 overexpressing	 SUMO	 molecules.	 Senp7	 is	 transiently	 activated	 at	 early	 stages	 of	








	 The	 identification	 of	 target	 proteins	 that	 change	 their	 SUMOylation	 state	 in	 cells	
between	 proliferative	 and	 differentiating	 conditions	 has	 always	 been	 an	 attracting	
endeavour	 during	 progression	 of	 this	 work,	 focusing	 our	 efforts	 in	 the	 purification	 of	
SUMOylated	 products	 in	 both	 conditions	 and	 their	 subsequent	 identification	 by	 mass	
spectrometry	 (MS).	 Problems	 associated	 to	 the	 highly	 dynamic	 fashion	 of	 the	 SUMO	
conjugation	and	the	low	amount	of	SUMOylated	forms	of	target	proteins	have	hindered	our	
progression	 to	 this	 point,	 till	 the	 establishment	 of	 a	 purification	 protocol	 in	 the	 group	 of	





	 After	 the	MS	 data	 processing,	 a	 further	 analysis	 to	 get	 a	 sight	 into	 the	 functional	
associations	in	cellular	processes	that	these	proteins	have	was	mandatory.	To	this	purpose,	
gene	 ontology	 (GO)	 analyses	 were	 conducted	 over	 genes	 coding	 for	 targets	 that	 were	
selected	because	of	 remarkable	differences	 in	 their	SUMOylation	states	compared	to	their	
expression	 levels	 between	 the	 studied	 conditions	 (relative	 SILAC)	 (Figure	 R-38).	 GO	
performed	over	genes	encoding	for	targets	that	are	presumably	modified	by	SUMO1	shows	
that	a	high	number	of	them	(34%)	are	related	to	transcriptional	regulation,	with	an	also	high	
number	 of	 genes	 implicated	 in	 general	 transcriptional	 processes	 (28%)	 (Table	 D-1).	 It	 is	





According	 to	 this	point,	 it	has	been	previously	discussed	how	transcriptional	 regulation	by	




attributed	 to	 chromatin	 organization	 stand	 out	 regarding	 these	 targets	 modified	 by	






























































































into	 consideration	both	 sets	of	 SILAC	 relative	 targets	 that	are	modified	by	SUMO1	and	by	




Table	D-2:	 Gene	 functions	 of	 SILAC	 relative	 SUMO	 targets.	Genes	 from	an	additional	GO	analysis	












































	 As	 previously	mentioned,	 targets	 identified	 in	 the	MS	 analysis	 change	 the	 ratio	 in	
which	 they	 show	 to	 be	 modified	 by	 SUMO,	 according	 to	 a	 remarkable	 change	 in	 their	
SUMOylation	levels	in	comparison	to	their	expression	levels	between	both	conditions	or	due	
to	a	high	change	in	their	expression	levels.	To	this	last	point,	it	would	be	important	to	study	
why	 SUMOylation	 of	 a	 specific	 target	 is	 important	 in	 one	 of	 the	 analysed	 conditions,	 and	
why	the	target	is	dumped	or	degraded	in	the	opposite	condition.	These	scenarios	have	to	be	
taken	 into	 consideration	 to	 further	 validate	 and	 investigate	 the	 identified	 targets.	 In	 this	
regard,	it	is	important	to	state	that	some	targets	might	be	mistakenly	excluded	from	the	lists	
of	 SILAC	 relative	 candidates,	 when	 they	 indeed	 change	 their	 SUMOylation	 levels	 in	 a	
significant	way	compared	to	changes	in	their	expression,	but	not	fulfilling	the	strict	criteria	
applied	 for	 the	 relative	 candidates	 in	 a	 quantitative	 way.	 This	 has	 been	 the	 case	 for	 the	
Interferon	 regulatory	 factor-2-binding	 protein-1	 (IRF2BP1).	 Our	 validation	 experiments	
unambiguously	 show	 that,	 although	 being	 excluded	 from	 the	 list	 of	 SILAC	 relative	
candidates,	 IRF2BP1	 is	 indeed	 more	 efficiently	 SUMOylated	 following	 neuronal	
differentiation	 than	under	proliferative	conditions,	without	great	 changes	 in	 its	expression	
level	 (Figure	 R-39).	 Thus,	 we	 do	 not	 exclude	 that	 additional	 proteins,	 not	 fitting	with	 the	
established	criteria	to	be	considered	as	SILAC	relative	candidates,	are	indeed	SILAC	relative	
candidates.	IRF2BP1	was	initially	described	to	mediate	corepressor	activity,	together	with	its	
interaction	 partner	 Interferon	 regulatory	 factor-2	 (IRF-2),	 over	 interferon	 (IFN)	 genes	
expression	(Childs,	KS	and	Goodbourn,	S,	2003).	In	later	works,	IRF2BP1	has	been	associated	
to	 regulation	 of	 the	 transforming	 growth	 factor	 (TGF)	 signalling	 pathway.	 In	 this	 regard,	
IRF2BP1	has	 been	 shown	 to	 antagonise	 the	 repressor	 activity	 of	 the	 Transforming	 growth	
interacting	 factor	 (TGIF),	 thus	 promoting	 the	 TGF-ß-mediated	 growth	 arrest	 and	 gene	
expression	(Faresse,	N	et	al.,	2008).	
	 On	 the	 other	 hand,	 we	 cannot	 rule	 out	 the	 possibility	 that	 some	 of	 the	 proteins	
identified	 as	 differentially	 SUMOylated	 are	 false	 positives.	 The	 fundament	 of	 mass	
spectrometry,	 which	 undergoes	 peptide	 digestion	 of	 the	 protein	 samples	 prior	 to	 the	
analysis,	 permits	 the	 detection	 of	 peptides	 corresponding	 to	 proteins	 that	 are	 not	
SUMOylated	but	have	been	 recognized	by	 the	 SUMO	antibodies	 in	 an	unspecific	way	 and	
therefore	eluted	in	the	immunoprecipitation	protocol.	Validation	of	the	different	candidates,	
one	by	one,	by	using	 specific	antibodies	will	unambiguously	 indicate	which	candidates	are	







	 To	 assess	 the	 implication	 of	 the	 SUMO	 modification	 of	 the	 selected	 targets	 in	
neuronal	 differentiation,	 functional	 experiments	 are	 required.	 The	 identification	 of	 the	
target	lysines	for	SUMO	modification	is	critical	for	each	of	the	selected	proteins.	As	mutation	
of	 the	 identified	 target	 lysines	 to	 arginine	 for	 the	 obtainment	 of	 effective	 SUMOylation	
mutants	will	 contribute	 to	get	 information	 from	functional	analyses,	either	on	P19	cells	or	
chicken	 embryos.	 The	 interpretation	 of	 the	 results	 will	 greatly	 depend	 on	 the	 neuronal	
differentiation	phenotype	obtained,	thus	arising	a	variety	of	possible	scenarios.	This	way,	a	
mutant	 protein,	 whose	 SUMOylation	 is	 necessary	 for	 proper	 differentiation	 of	 neural	
progenitors,	 may	 have	 an	 effect	 in	 disrupting	 or	 somehow	 impairing	 neuronal	
differentiation,	 but	 in	 the	 case	 that	 SUMOylation	 of	 this	 protein	 is	 needed	 in	 neural	
progenitors	 for	 the	 maintenance	 of	 a	 proliferative	 state,	 the	 mutant	 may	 promote	 and	
increase	differentiation	upon	 induction	of	neurogenesis	with	neurogenic	 factors.	 It	 is	 likely	
to	think	that	the	obtainment	of	analysable	phenotypes	will	depend	in	a	great	manner	on	the	
degree	 of	 implication	 that	 this	 factors	 would	 have	 in	 neuronal	 differentiation	 and	 their	
function	 on	 early	 stages	 of	 the	 differentiation	 cascade.	 A	 function	 on	 later	 stages	 will	
presumably	 do	 necessary	 the	 analysis	 of	 specific	 neuron	 subtypes	 for	 the	 detection	 of	 a	
given	phenotype.	
	 As	 has	 been	 previously	 shown,	 we	 have	 currently	 validated	 SUMOylation	 of	 some	
interesting	 proteins	 identified	 by	MS	 (Figure	R-39).	Our	 interest	 has	 been	 initially	 focused	
into	 proteins	 related	 to	 transcriptional	 regulation	 like	 TRIM24,	 MORC3	 or	 ATRX,	 or	 the	
previously	 mentioned	 IRF2BP2,	 taking	 into	 consideration	 that	 some	 of	 them	 have	 never	
been	 showed	 to	 be	 SUMOylated.	 TRIM24	 is	 a	member	 of	 a	 large	 family	 of	 proteins	 that	




and	 has	 been	 associated	 to	 cell	 signalling	 by	 RA	 (reviewed	 in	 (Gudas,	 LJ	 and	Wagner,	 JA,	





domain	 and	 a	 Bromo	 domain.	 Interestingly,	 the	 PHD	 domain	 of	 TRIM28	 (also	 termed	 as	
KAP1)	 has	 been	 shown	 to	 confer	 this	 protein	 an	 intramolecular	 E3	 SUMO	 ligase	 function	
(Zeng,	L	et	al.,	2008),	 raising	 the	possibility	of	TRIM24	also	acting	as	an	E3	 ligase,	proteins	
that	often	tend	to	be	modified	by	SUMO.	
	 The	 transcriptional	 regulator	ATRX	 is	an	ATP-dependent	helicase	protein	comprised	
by	two	zinc-finger	domains	and	an	ATPase	domain.	This	protein	has	been	implicated	in	the	




the	 action	 of	 the	 ATRX/Daxx	 complex	 to	 the	 maintenance	 of	 H3K9me3	 in	 telomeres,	
pericentric	 heterochromatin,	 methylated	 CpG	 islands	 and	 other	 regions	 of	 the	 genome	
(reviewed	in	(Voon,	HP	and	Gibbons,	RJ,	2016;	Voon,	HP	and	Wong,	LH,	2016)).	 Interesting	
associations	 between	 ATRX	 function	 and	 the	 maintenance	 of	 synaptic	 plasticity	 and	
homeostasis	 have	 been	 established	 when	 analysing	 the	 pathobiology	 of	 the	 mental	
retardation	 Rett	 syndrome.	Mutations	 in	 the	methyl-CpG	binding	 protein	 2	 (MeCP2)	 have	
been	 classically	 associated	 with	 this	 syndrome	 (Bellini,	 E	 et	 al.,	 2014),	 and	 it	 has	 been	
proposed	 how	 the	 disorganized	 structure	 of	 this	 protein	 allows	 for	 a	 variety	 of	 post-
translational	modifications,	including	SUMOylation	(Cheng,	J	et	al.,	2014;	Tai,	DJ	et	al.,	2016),	
that	orchestrate	the	transcriptional	regulatory	functions	attributed	to	this	protein.	
	 Microrchidia	 family	 CW-type	 zinc-finger	 3	 (MORC3)	 is	 a	 zinc-finger	 protein	 that	
belongs	 to	 the	 family	 of	MORC	 proteins,	 characterized	 by	 the	 presence	 of	 an	 N-terminal	
ATPase	 domain,	 a	 zinc-finger	 domain,	 a	 NLS	 and	 a	 coiled-coil	 domain	 located	 to	 the	 C-
terminal	 part	 (Kimura,	 Y	 et	 al.,	 2002).	 MORC3	 has	 been	 associated	 to	 p53	 regulation,	
mediating	 the	 recruitment	 of	 the	 tumour	 suppressor	 protein	 into	 promyelocytic	 leukemia	

















interesting	 role	 in	 neuronal	 differentiation	 emerges	 from	 its	 capability	 of	 regulating	 an	
important	 subset	 of	 genes	 to	 promote	 cell	 cycle	 exit	 and	 neuronal	 differentiation,	 while	
inhibiting	astrogliogenesis	(Stergiopoulos,	A	et	al.,	2014).	
	 In	 conclusion,	 the	 further	 establishment	 of	 functional	 roles	 for	 the	 SUMO	
modification	of	identified	proteins	in	the	process	of	neuronal	differentiation	will	help	us	to	
understand	 the	 signalling	 mechanisms	 involved	 in	 this	 process.	 A	 subset	 of	 identified	
proteins	start	 to	arise	as	promising	candidates	 to	perform	more	detailed	experiments	 that	








1) The	 transcription	 factor	 Krox20	 interacts	 in	 a	 direct	 and	 specific	 manner	 with	 the	
SUMO	 conjugating	 enzyme	Ubc9	 through	 the	 zinc-finger	 domain	 present	 in	 Krox20.	 Since	
Krox20	 interaction	with	Nab	corepressors	occurs	 through	 the	R1	domain,	Krox20	 interacts	
with	Nab	proteins	and	Ubc9	through	different	domains.	
	
2) Krox20	 acts	 as	 an	 E3	 SUMO	 ligase	 for	 the	modification	 of	Nab	 proteins	 (Nab1	 and	






4) Krox20-mediated	 SUMOylation	 of	 Nab	 proteins	 leads	 to	 repression	 of	 Krox20	
transcriptional	activity	during	hindbrain	formation.	
	
5) Levels	of	SUMOylated	proteins	decrease,	while	 levels	of	 free	SUMO	pools	 increase,	
following	 induction	 of	 neuronal	 differentiation.	 This	 agrees	 with	 impairment	 in	 neuronal	
differentiation	provoked	by	SUMO	overexpression.	
	
6) Expression	 levels	 of	 Senp7	 and	 Senp5	 are	 upregulated	 following	 induction	 of	
neuronal	differentiation,	while	expression	 levels	of	other	 components	of	 the	SUMOylation	
pathway	are	not	significantly	altered.	
	






8) SUMO	 immunoprecipitation	 following	 specific	 peptide	 elution	 can	 efficiently	 purify	






10) A	 significant	 number	 of	 proteins	 that	 change	 their	 SUMOylation	 state	 during	
















Name	 Prom.	 Res.	 Information	 Source	
pBS-SK	(+)	 T3/T7	 Amp	 Cloning	backbone	RNA	probe	synthesis	 Stratagene	
pBS	KS	(+)	 T3/T7	 Amp	 Cloning	backbone	 Stratagene	








pGEX-6P-3	 tac	 Amp	 Cloning	backbone	 GE	Healthcare	
pGEX-6P-3-Ubc9	 tac	 Amp	 Ubc9	expression	for	purification	
This	work	
(Garcia-Gutierrez,	P	et	al.,	2011)	
pGEX-6P-3-Aos1	 tac	 Amp	 Aos1	expression	for	purification	
This	work	
(Garcia-Gutierrez,	P	et	al.,	2011)	
pGEX-6P-3-Uba2	 tac	 Amp	 Uba2	expression	for	purification	
This	work	
(Garcia-Gutierrez,	P	et	al.,	2011)	






















Name	 Prom.	 Comp.	 Res.	 Information	 Source	
pDBLeu-Krox20*	 ADH	 Leu	 Km	 Two-hybrid	(bait)	 Invitrogen	
pPC86	 ADH	 Trp	 Amp	 Two-hybrid	(prey)	 Invitrogen	
	
*	Deletion	mutants	in	Figure	R-2	were	obtained	through	standard	PCR	techniques	based	on	





Name	 Prom.	 Res.	 Information	 Source	


































































































pGL4.51	 CMV	 Amp	 Constitutive	Luciferase	reporter	 Promega	







pCS2-MT-E12	 CMV	 Amp	 E12	overexpression	 Dr.	Kristen	L.	Kroll	(Seo,	S	et	al.,	2005)	
pmCherry-N1	 CMV	 Km	 Constitutive	mCherry	reporter	 Clontech	
pEGFP-N1	 CMV	 Km	 Constitutive	GFP	reporter	 Clontech	







phS7P-GFP	 SENP7p	 Km	 GFP	reporter,	SENP7	(h)	promoter-driven	
This	work	
(Juarez-Vicente,	F	et	al.,	2016)	















































































































































































































































Name	 Conjugate	 Host	 Source	 Dilution	
Anti-mouse	IgG	 HRP	 Goat,	polyclonal	 Sigma-Aldrich	(A4416)	 1:10000	(WB)	
Anti-rabbit	IgG	 HRP	 Goat,	polyclonal	 Sigma-Aldrich	(A6154)	 1:10000	(WB)	
Anti-rat	IgG	 HRP	 Goat,	polyclonal	 Sigma-Aldrich	(A9037)	 1:10000	(WB)	




















































at	 250	 rpm.	 The	 culture	 medium	 employed	 was	 YPD	 consisting	 on	 10	 g/l	 yeast	 extract,	
20	g/l	of	tryptone	and	20	g/l	of	glucose.	For	growing	restrictions,	essential	minimal	medium	




	 HEK	 293T	 cells	 were	 cultured	 in	 DMEM	 (Dulbecco’s	 Modified	 Eagle’s	 Medium)	
commercially	 supplemented	 with	 4.5	 g/l	 D-glucose,	 L-glutamine,	 sodium	 pyruvate	 and	
sodium	bicarbonate	(Sigma-Aldrich).	500	ml	of	medium	were	supplemented	with	10%	(v/v)	
fetal	 bovine	 serum	 (FBS)	 and	 10	 ml	 of	 a	 solution	 consisting	 on	 100	 U/ml	 penicillin	 and	
100	µl/ml	 streptomycin	 (P/S).	 The	 cells	were	 subcultured	 for	weekly	maintenance	 at	 1/10	
dilution	from	an	almost	confluent	plate	washing	the	cells	with	PBS,	detaching	with	Trypsine-
EDTA	and	diluting	them	in	fresh	medium.	
	 P19	 cells	 were	 cultured	 in	 αMEM	 (alpha	 modification	 Minimum	 Eagle’s	 Medium)	
commercially	 supplemented	with	4.5	g/l	D-Glucose,	L-glutamine,	 sodium	pyruvate,	 sodium	



















was	 necessary.	 It	 was	 performed	 using	 the	 Expand	 High	 Fidelity	 (Roche)	 kit	 and	 a	
TC3000	(Techne)	thermal	cycler.	Each	PCR	reaction	was	conducted	in	a	total	volume	of	50	µl,	





step	at	variable	 temperature	 (depending	on	 the	Tm	for	each	primer)	 for	1	min	and	a	 final	




	 For	DNA	 fragments	digestion,	diverse	 restriction	enzymes	 (Fermentas,	 Takara,	New	
England	 Biolabs)	 were	 employed	 following	 the	manufacturer’s	 instructions,	 in	 addition	 to	
the	 appropriate	 restriction	 buffer	 and	 digestion	 temperature.	 For	 blunt	 end	 production	










	 For	 the	 ligation	 of	 DNA	 fragments,	 the	 T4	 DNA	 ligase	 (Promega)	 was	 employed,	




	 Antisense	 RNA	 probes	 were	 synthesized	 for	 in	 situ	 hybridization	 experiments.	 For	
this,	 cDNA	 constructs	 for	 EphA4,	 HoxB1	 and	 Krox20	 were	 linearized	 with	 NotI,	 XbaI	 and	
HindIII	 restriction	enzymes	(Fermentas),	respectively,	analysing	the	restriction	efficiency	by	
electrophoresis	in	0.8%	(w/v)	agarose	gels,	as	further	explained.	RNA	probes	were	obtained	
by	 transcription	 of	 the	 linearized	 plasmids,	 using	 the	 RNA	 T3	 or	 T7	 polymerases	 with	 a	







	 Total	 RNA	 isolation	 from	mammal	 cells	 was	 performed	 with	 the	 RNeasy®	mini	 Kit	
(QIAGEN),	according	to	the	manufacturer’s	instructions.	For	RNA	quality	monitoring,	1	µl	of	
each	 RNA	 sample	was	 supplemented	with	 1	 µl	 of	 10x	 loading	 buffer	 in	 a	 total	 volume	 of	




	 Prior	 to	 cDNA	 synthesis,	 contaminant	 DNA	 was	 erased	 with	 the	 RQ1	 RNase-Free	
DNase	(Promega)	kit,	according	to	the	manufacturer’s	instructions.	For	these	cases,	1	µg	of	
RNA	was	treated	with	1	unit	of	DNase.	For	the	obtainment	of	cDNA,	the	SuperScript®	First-
Strand	 Synthesis	 System	 (Invitrogen)	 kit	 was	 employed,	 following	 the	 manufacturer’s	









		 Electrophoresis	 of	 DNA	 samples	 in	 agarose	 gels	 was	 conducted	 in	 order	 to	 isolate	
DNA	 fragments	 and	 PCR	 reactions,	 or	 for	 restriction	 analysis	 of	 DNA	 constructs.	
Electrophoresis	of	RNA	fragments	was	conducted	to	monitorize	the	systhesis	of	RNA	probes	
and	quality	of	total	RNA	isolation.	For	this	purpose,	depending	on	the	DNA	or	RNA	fragment	
size,	 0.5-2%	 (w/v)	 agarose	 gels	were	 prepared	 by	 dissolving	 the	 required	 amount	 of	 pure	
agarose	 in	 0.5x	 TBE	 buffer	 (45	mM	Tris-borate,	 1	 mM	 EDTA	 pH	 8.0).	 After	 boiling	 the	
suspension	 in	 a	 microwave,	 5	 µg/ml	 of	 ethidium	 bromide	 were	 added	 to	 stain	 the	
nucleotides.	 The	mixture	 was	 placed	 on	 electrophoresis	 chambers	 with	 combs	 and,	 after	
cooling	 down	 and	 gelification,	 covered	 with	 0.5x	TBE	buffer.	 DNA	 and	 RNA	 samples	 were	




at	 60-100	 V	 and	 DNA	 or	 RNA	 was	 revealed	 using	 a	 Universal	 Hood	 II	 (BIO-RAD)	 trans-



























	 Preparation	 of	 E.	 coli	 BL21	 (DE3)	 electrocompetent	 bacteria	 was	 conducted	 as	
described	in	(Green,	MR	and	Sambrook,	J,	2012).	
	 For	routinely	electroporation,	50	µl	of	thawed	electrocompetent	bacteria	were	mixed	
with	 up	 to	 25	 ng	 of	 salt-free	 DNA	 and	 maintained	 on	 ice.	 Meanwhile,	 electroporation	
cuvettes	(VWR)	with	0.2	cm	spaced	electrodes	were	also	chilled	on	ice	and	a	MicroPulserTM	
(Biorad)	 electroporator	 was	 set	 for	 bacteria,	 selecting	 program	 2	 for	 the	 mentioned	










	 The	 alkaline	 lysis	 method	 was	 followed	 (Sambrook,	 J	 and	 Gething,	 MJ,	 1989).	 For	












	 For	 medium-scale	 preparations,	 the	 JETStarTM	 (GENOMED)	 purification	 kit	 was	
employed,	 following	 the	 manufacturer’s	 instructions.	 After	 plasmid	 elution,	 DNA	
precipitation	was	performed	 for	plasmid	concentration	by	addition	of	ethanol	and	sodium	













were	mixed	with	 5	 µl	 of	 DNA	 carrier	 solution	 (10	mg/ml	 of	 salmon	 sperm,	 boiled	 during	







	 For	DNA	purification	 from	agarose	gels,	or	 in	 the	case	 that	higher	DNA	quality	was	
required	 from	 DNA	 preparations	 (e.g.	 for	 DNA	 sequencing),	 the	 FavorPrep™	 GEL/PCR	















promoter	 driven	 luciferase	 expression	 vector	 pGL4.51	 (Promega)	 was	 used	 for	




	 For	 protein	 crosslink	 to	 the	 chromatin,	 P19	 cells	 were	 treated	 on	 their	 10	 cm	 ø	
adherent	 plates,	 supplementing	 the	 medium	 with	 crosslink	 buffer	 (5	mM	 HEPES	 pH	 8.0,	




and	 centrifuged	 for	 5	min	 at	 1500x	 g.	 The	 cell	 pellet	 was	 then	 lysed	with	 2.5	ml	 of	 lysis	
buffer	1	(5	 mM	 piperazine-N,	 Nʹ-bis	 (2-ethanesulfonic	 acid)	 (PIPES)	 pH	 8.0,	 85	 mM	 KCl,	
0.5%	(v/v)	NP40),	following	incubation	at	room	temperature	for	5	min	and	centrifugation	for	
5	min	at	3600x	g	and	4°	C.	The	pellet	was	 resuspended	and	 lysed	 in	1	ml	of	 lysis	buffer	2	
(1%	(w/v)	 SDS,	 10	mM	 EDTA	 pH	 8.0,	 50	mM	Tris-HCl	pH	8.1)	 supplemented	 with	 protease	
inhibitors.	
	 The	 lysates	 were	 sonicated	 on	 ice	 to	 shear	 DNA,	 using	 a	 Bioruptor	 (Diogenode)	
sonifier,	with	 eight	 pulses	 of	 30	 s	 each	 at	 high	output	 and	 a	 pause	of	 30	 s	 between	each	
pulse,	following	centrifugation	for	5	min	at	3600x	g	and	4°	C	to	recover	the	chromatin	in	the	
supernatant.	An	aliquot	of	50	µl	from	the	total	chromatin	was	then	digested	adding	350	µl	of	








gel.	For	 input	controls	 from	each	sample,	10	µl	of	 the	total	chromatin	were	taken	prior	 to	
incubation	with	the	antibodies.	
	 To	perform	the	chromatin	immunoprecipitation,	30	µg	of	quantified	chromatin	from	
each	 sample	were	diluted	1/10	 in	 IP	buffer	 (0.01%	 (w/v)	 SDS,	1.1%	 (v/v)	Triton	X-100,	1.2	
mM	 EDTA	 pH	 8.0,	 16.7	mM	 Tris-HCl	 pH	 8.1,	 167	mM	NaCl)	 supplemented	with	 protease	
inhibitors.	The	monoclonal	D-11	SUMO1	antibody	(sc-5308,	Santa	Cruz	Biotechnology)	or	the	
monoclonal	M2	 Flag	 antibody	 (A2220,	 Sigma-Aldrich)	 were	 then	 added	 as	 requested	 and	
incubated	over	night	under	 rotation	at	4°	C.	An	additional	non-specific	 interaction	 control	
was	included	per	sample	with	normal	mouse	IgG	(Sigma-Aldrich).	Next,	1	µl	protein	G	beads	
(Roche)	per	µg	of	chromatin,	previously	washed	and	equilibrated	in	IP	buffer,	was	added	and	
incubated	 for	 2	 h	 under	 rotation	 at	 4°	 C	 to	 collect	 proteins-DNA	 complexes.	 Then,	 beads	
were	subsequently	washed	with	1	ml	of	washing	buffer	1	(0.1%	(w/v)	SDS,	1%	(v/v)	Triton	X-





	 The	 protein-DNA	 complexes	 were	 eluted	 by	 incubating	 the	 beads	 with	 80	 µl	 of	










	 Quantitative	 PCR	 analysis	 was	 used	 in	 this	 work	 to	 analyse	 gen	 expression	 and	 to	
monitor	 incorporation	 of	 proteins	 to	 specific	 DNA	 sequences	 by	 chromatin	 immuno-
precipitation.	The	Primer3Plus	tool	was	employed	for	the	design	of	qPCR	primers	(see	Table	




primers	 of	 60°	 C.	 Primers	 were	 synthesized	 by	 Sigma-Aldrich	 and	 tested	 by	 analysis	 of	 a	




was	 employed	 for	 the	 preparation	 of	 each	 PCR	 reaction,	 following	 the	 manufacturer’s	
instructions	 and	 in	 cold	 conditions.	 For	 ChIP	 analysis,	 3	 µl	 from	 a	 1/10	 dilution	 of	 the	
obtained	final	DNA	samples	were	included	in	each	reaction.	For	the	P19	cDNA	analysis,	3	µl	
from	 a	 1/10	 dilution	 of	 the	 total	 cDNA	 were	 included	 in	 each	 reaction,	 performed	 in	
triplicates.	 For	 plate	 sealing,	 adhesive	 film	 (VWR)	 was	 used.	 For	 Ct	 values	 normalization,	
GAPDH	was	 analysed	 in	ChIP	 experiments	 and	 r18S	RNA	was	 analysed	 in	 gene	expression	




cycle	 consisting	 on	 15	 s	 at	 95°	 C,	 1	 min	 at	 65°	 C,	 15	 s	 at	 95°	 C	 and	 15	 s	 at	 60°	 C,	 was	
performed	to	detect	possible	contaminants.	Algorithms	for	calculation	of	relative	units	and	





by	 the	 use	 of	 specific	 RNA	 probes.	 For	 this	 purpose,	 following	 rehydration	 of	 chicken	
embryos	in	PBS,	hindbrains	were	dissected	from	the	embryos	and	digested	in	1.5	ml	tubes	
with	20	µg/ml	of	proteinase	K	(Roche)	in	PBTr	0.1	(0.1%	(v/v)	Triton	X-100	in	PBS)	for	12	min	





tRNA,	 0.1%	 (v/v)	 CHAPS	 and	 0.1%	 (w/v)	 SDS)	 for	 2	 h	 at	 65°	 C	 under	 agitation.	 Then,	






agitation.	 After	 three	 washes	 of	 20	min	 each	 with	 2x	 SSC	 +	 0.1%	 (v/v)	 CHAPS	 and	 three	
additional	 washes	 with	 0.2x	 SSC	 +	 0.1	 (v/v)	 CHAPS,	 hindbrains	 were	 equilibrated	 in	 KTBT	
solution	 (50	mM	 Tris-HCl	 pH	 7.5,	 150	mM	NaCl,	 20	mM	 KCl,	 0.1%	 (v/v)	 Triton	 X-100)	 for	
10	min	at	room	temperature.	





	 Revelation	 of	 hybridized	 probes	 was	 conducted	 by	 equilibrating	 the	 hindbrains	 in	
NTMTL	solution	(0.1	M	Tris-HCl	pH	9.5,	50	mM	MgCl2,	0.1	M	NaCl,	0.1%	(v/v)	Triton	X-100	
and	0.5	mg/ml	Levamisole	(Sequoia	Research	Products	Ltd)),	following	incubation	with	fresh	
NTMTL	 supplemented	 with	 NBT	 or	 BCIP	 substrate	 (Roche)	 for	 digoxigenin	 or	 fluorescein	
staining,	respectively,	 in	darkness	at	room	temperature	till	 tissue	staining	was	appreciable.	
Revelation	was	 stopped	with	 subsequent	washes	with	 PBTr	 0.1	 and	 then	hindbrains	were	
mounted	on	cover	slides	for	 image	acquisition	with	a	epifluorescence	DM6000	microscope	
(Leica	Microsystems	GmbH).	








	 To	 perform	 transient	 transfection	 of	 P19	 growing	 in	 αMEM	 +	 7.5%	 (v/v)	 NCS	 +	
2.5%	(v/v)	FBS	+	P/S	or	HEK-293T	cells	growing	in	DMEM	+	10%	(v/v)	FBS	+	P/S,	a	number	of	
cells	were	 seeded	 in	adherent	10	 cm	ø	plates,	6x	or	12x	well	plates	and	 transfected	after	
24	h	with	1	µg,	2	µg	or	10	µg	of	DNA	respectively.	For	this	purpose,	the	Lipofectamine®	2000	











	 To	obtain	neuron	differentiated	P19	 cells,	 5·105	 cells	were	 seeded	 in	non-adherent	
sterile	10	cm	ø	plates	(Monolab)	and	grown	in	suspension	with	αMEM	+	5%	(v/v)	FBS	+	P/S	+	
2	µM	RA	during	4	d,	refreshing	the	medium	the	second	day.	The	fourth	day,	when	embryonic	
bodies	 were	 properly	 formed,	 they	 were	 harvested	 into	 15	 mL	 tubes	 and	 centrifuged	 at	
1,500x	 g	 for	 5	min	 and	media	was	 removed,	 resuspending	 the	 embryonic	 bodies	 in	 fresh	
αMEM	 +	 7.5%	 NCS	 +	 2.5%	 FBS	 +	 P/S	 without	 any	 RA.	 Embryonic	 bodies	 were	 then	
mechanically	 disaggregated	with	 a	 10	ml	 pipette	 and	 seeded	 in	 adherent	 10	 cm	 ø	 plates	
(Nunc)	for	three	more	days.	During	this	last	period,	axon	and	dendrite-like	processes	start	to	








10	 µg/ml	 streptomycin	 +	 146	µg/ml	 Lys	 +	 84	 µg/ml	 Arg)	 supplemented	 with	 10%	 (v/v)	
dialysed	FBS,	or	grown	in	heavy	AA	medium	(Silantes	DMEM	+	2	mM	L-Glutamine	+	10	ml	of	
penicillin/streptomycin	 +	 146	µg/ml	 D4	 Lys	 +	 84	 µg/ml	 [13C]Arg)	 supplemented	 with	 10%	
(v/v)	 dialysed	 FBS.	 During	 these	 four	 days,	 sufficient	 to	 achieve	 around	 six	 cell	 division	
rounds,	the	cells	incorporated	the	SILAC	specific	amino	acids.	
	 For	 the	 first	 experiment,	 2·106	 of	 the	 cells	 grown	 in	 the	 heavy	 AA	 condition	were	












20	mM	NEM,	2	mM	Pefabloc	and	2	mg/ml	of	protease	 inhibitors	 (aprotinin,	 leupeptin	and	
pepstatin)	 in	 PBS)	 by	 scrapping	 the	 cells	 directly	 on	 the	 plates	 with	 the	 lysis	 buffer	 and	
obtaining	a	total	lysate	volume	of	approximately	15	ml.	In	the	case	of	differentiating	cells,	a	
total	 amount	 of	 approximately	 9·108	 suspended	 cells	were	 harvested	 by	 centrifugation	 at	
500x	g	for	5	min,	washed	in	cold	PBS	+	10	mM	NEM	and	resuspended	in	a	total	volume	of	16	
ml	 of	 PBS.	 Then,	 cells	 were	 lysed	 adding	 16	 ml	 of	 2x	 lysis	 buffer.	 The	 cell	 lysates	 were	
snap-freezed	with	liquid	nitrogen	and	stored	at	-80°	C.	
	 To	perform	the	reverse	experiment,	2·106	of	the	cells	grown	in	the	light	AA	condition	
were	 seeded	 in	 45	 adherent	 plates	 for	 proliferation,	 and	 still	 grown	 in	 light	 AA	 medium	
supplemented	 with	 10%	 (v/v)	 dialysed	 FBS	 for	 two	 more	 days	 before	 harvesting	 them.	






	 To	 induce	protein	 expression	dependent	on	 serum	 stimulation	 in	 P19	 cells,	 1.5·105	
cells	were	seeded	 in	6x	well	plates	and	 initially	grown	in	αMEM	+	0.1%	(v/v)	FBS	+	P/S	for	

















by	 immunofluorescence.	 The	 DNA	 solution	 was	 injected	 in	 the	 lumen	 of	 the	 neural	 tube	
using	a	glass	capillary	and	the	embryos	were	electroporated	at	the	hindbrain	or	the	neural	
tube	level	with	a	BTX820	(Quantum)	electroporator,	employing	4	or	6	pulses,	respectively,	of	














	 In	vitro	 translation	 in	 the	presence	of	 [35S]Met	was	performed	with	 the	TnT®	Quick	





E.	coli	by	cloning	 the	cDNA	sequence	 into	a	pGEX-6P-3	 (GE	Healthcare)	vector	 for	 the	GST	
constructs,	 or	 a	 pET28a+	 (Novagen)	 vector	 for	 the	polyhistidine-tagged	 construct.	 For	 this	





















	 This	 technique	 was	 performed	 in	 the	 cases	 that	 denaturing	 conditions	 had	 to	 be	
achieved	 during	 protein	 extraction	 to	 preserve	 protein	 extracts	 from	 the	 action	 of	
peptidases.	For	this	purpose,	thorough	lysis	of	harvested	cells	was	conducted	in	urea	buffer	
(8	M	urea,	 10	mM	Tris-HCl	 pH	8.0),	 using	 a	 1	ml	 syringe	with	 a	 0.5	mm	ø	needle	 (BD)	 to	





	 Alternatively,	 for	 also	 preserving	 protein	 extracts	 from	 the	 action	 of	 peptidases,	
harvested	cells	were	lysed	in	SDS	buffer	(1%	SDS	wt/v,	5	mM	EDTA,	5	mM	EGTA,	10	mM	N-
ethylmaleimide	 (NEM),	 1x	 cOmpleteTM	 Protease	 Inhibitor	 Cocktail	 (Roche)	 in	 PBS)	 and	
sonicated	using	a	Digital	 Sonifier	S-450D	 (Branson)	with	a	3	mm	microtip.	The	parameters	
were	set	to	6	pulses	of	30	s	each	at	10%	amplitude,	with	a	pause	of	30	s	between	each	pulse.	
Protein	 extracts	 were	 then	 centrifuged	 for	 15	 min	 at	 15000x	 g	 and	 supernatant	 was	






	 When	non-denaturing	 conditions	had	 to	be	maintained,	 harvested	 cells	were	 lysed	
with	Triton	buffer	(50	mM	Tris-HCl	pH	7.5,	150	mM	NaCl,	1%	(v/v)	Triton	X-100,	1	mM	EDTA	
and	 1x	cOmpleteTM	 Protease	 Inhibitor	 Cocktail	 (Roche))	 or	 NP-40	 buffer	 (50	 mM	 Tris-HCl	
pH	8.0,	 150	 mM	 NaCl,	 1%	 (v/v)	 Nonidet	 P-40,	 0.5%	 (w/v)	 sodium	 deoxycholate	 and	
1x	cOmpleteTM	Protease	 Inhibitor	Cocktail	 (Roche))	as	 indicated.	Lysates	were	then	kept	on	
ice	for	30	min.	After	centrifugation	and	protein	quantification	of	the	supernatants,	protein	






	 GST-tagged	 proteins	 were	 heterologously	 expressed	 in	 bacteria	 by	 induction	 with	
IPTG	 and	 then	 purified	 by	 glutathione-affinity	 chromatography	 using	 a	 Glutathione	
SepharoseTM	4B	(GE	Healthcare)	matrix,	following	the	manufacturer’s	instructions.	Then,	the	
adsorbed	 proteins	 were	 eluted	 with	 10	 mM	 reduced	 glutathione	 or	 cleavaged	 from	 GST	
using	the	PreScission	(GE	Healthcare)	enzyme	according	to	the	manufacturer’s	instructions.	






Krox20	 (1/10	of	 the	reaction)	 in	200	µl	of	binding	buffer	 (20	mM	Tris-HCl	pH	7.0,	100	mM	
NaCl,	1	mM	EDTA,	10%	glycerol,	0.01%	Nonidet	P40)	and	washed,	 first	with	binding	buffer	











	 This	 protocol	 was	 used	 for	 pulling	 down	 polyhistidine-tagged	 proteins,	
heterologously	 expressed	 in	 mammal	 cells	 after	 transfection	 or	 after	 protein	 purification	
from	bacteria	through	expression	induction	with	IPTG.	
	 For	pull-down,	the	cell	pellets	were	thoroughly	lysed	in	lysis	buffer	(0.1	M	phosphate	
buffer	 pH	 8.0,	 8	 M	 urea)	 with	 a	 1	 ml	 syringe	 connected	 to	 a	 0.5	 mm	 ø	 needle	 (BD)	 to	
mechanically	break	DNA.	After	centrifugation	for	10	min	at	16000x	g,	protein	concentration	
in	 the	 supernatant	 was	 determined	 and	 inputs	 taken.	 Then,	 50	 µl	 of	 His-Select®	 Nickel	













at	1500x	 g,	 following	 lysis	 in	 IP	 buffer	 (50	 mM	 Tris-HCl	 pH	 8.0,	 150	 mM	 NaCl,	
1.5	mM	EDTA	pH8.0,	1x	cOmpleteTM	Protease	Inhibitor	Cocktail	(Roche))	+	1%	(v/v)	Triton	X-
100	by	rotating	the	suspension	for	10	min	at	room	temperature.	After	centrifugation	for	10	
min	 at	 10000x	 g,	 total	 protein	 in	 the	 supernatants	was	quantified	 and	 inputs	were	 taken.	
Then,	 Triton	 X-100	 concentration	 was	 lowered	 to	 0.33%	 (v/v)	 adding	 IP	 buffer	 without	
detergent.	 Flag-tagged	 proteins	 were	 then	 immunoprecipitated	 using	 the	 Anti-Flag®	 M2	
(Sigma-Aldrich)	affinity	gel,	according	to	the	manufacturers	instructions.	
	 For	 this,	 Anti-Flag	 beads	 were	 added	 to	 the	 protein	 extracts	 and	 incubated	 for	







	 For	 enrichment	 of	 SUMOylated	 products,	 an	 immunoprecipitation	 protocol	 that	







(5	mM	 EDTA,	 5	mM	 EGTA,	 10	mM	NEM,	 1	mM	 Pefabloc	 and	 1	mg/ml	 each	 of	 protease	
inhibitors)	 and	 adding	 10	 mM	 NEM.	 For	 each	 set	 of	 experiments,	 proliferative	 and	
differentiated	 cell	 lysates	 were	 then	 mixed	 in	 a	 protein	 proportion	 of	 1:1,	 after	 protein	
quantification,	 and	 inputs	 from	 each	 set	 of	 experiments	 were	 taken.	 For	 the	 first	
experiment,	150	ml	of	 lysate	from	the	proliferative	condition	at	a	protein	concentration	of	
0.825	 mg/ml	 were	 mixed	 with	 160.5	 ml	 of	 lysate	 from	 the	 differentiating	 condition	 at	 a	
protein	concentration	of	0.77	mg/ml,	resulting	in	310.5	ml	of	combined	lysate.	
	 For	 the	 second	 experiment,	 150	ml	 of	 lysate	 from	 the	 proliferative	 condition	 at	 a	
protein	 concentration	 of	 1.2	 mg/ml	 were	 mixed	 with	 180	 ml	 of	 lysate	 from	 the	
differentiating	 condition	 at	 a	 protein	 concentration	 of	 1.0	 mg/ml,	 resulting	 in	 330	 ml	 of	
combined	lysate.	
	 For	the	SUMO	immunoprecipitation,	each	combined	lysate	was	equally	splitted	into	
three	 batches	 and	 1	ml	 of	 beads,	 coupled	 with	 control	 IgG	 or	 with	 SUMO1	 or	 SUMO2/3	
antibodies,	 were	 added	 per	 immunoprecipitation	 and	 incubated	 over	 night	 at	 4°	 C	 under	
rotation.	 After	 taking	 flow-through	 samples,	 beads	 were	 washed	 three	 times	 with	 RIPA	
buffer	(0.1%	(w/v)	SDS,	5	mM	EDTA,	5	mM	EGTA,	10	mM	NEM,	1	mM	Pefabloc	and	1	mg/ml	
each	 of	 aprotinin,	 leupeptin	 and	 pepstatin)	 and,	 after	 a	 pre-elution	 step	with	 pre-elution	
buffer	 (20	mM	phosphate	buffer	 pH	 7.4,	 500	mM	NaCl,	 1%	 (v/v)	 Triton	 X-100,	 0.5%	 (w/v)	
sodium	 deoxycholate,	 0.1%	(w/v)	 SDS,	 5	 mM	 EDTA,	 5	 mM	 EGTA,	 10	 mM	 NEM,	 1	 mM	















	 The	 two-hybrid	 system	 ProQuestTM	 Two-Hybrid	 System	 (Invitrogen)	 was	 employed	
with	 a	 Krox20	 deletion	 construct	 lacking	 its	 trans-activation	 domains	 and	 a	 cDNA	 library	
(Invitrogen)	from	8.5	days	whole	mouse	embryo,	to	search	for	protein-protein	 interactions	
with	Krox20.	The	cDNA	insert	had	an	average	size	of	1.2	kb	and	was	directionally	cloned.	






MaV203	 strain	 of	 S.	cerevisiae,	 the	 chimeric	 transcription	 factor	 is	 reconstituted	 and	
activates	 the	 expression	 of	 reporter	 genes	 HIS3	 (that	 allows	 growth	 in	 histidine-free	
medium)	 and	 LacZ	 (whose	 expression	 leads	 to	 colour	 appearance	 when	 treating	 with	 5-


















	 Protein	 extracts	 were	 quantified	 by	 Bradford	 method.	 For	 this	 purpose,	 3	 µl	 of	
protein	extract	were	mixed	to	1	ml	of	Dye	Reagent	Concentrate	(Bio-Rad).	After	incubating	
the	 mixture	 for	 5	 min,	 absorbance	 was	 measured	 at	 595	 nm	 with	 a	 DU®	 800	 spectro-
photometer	(Beckman	Coulter)	and	protein	concentration	was	obtained	using	a	calibration	




	 SDS	 polyacrylamide	 gel	 electrophoresis	 was	 employed	 for	 molecular	 weight-






polymerized	 2-propanol	 was	 removed,	 stacking	 buffer	 (0.125	 M	 Tris-HCl	 pH	 6.8,	 4%	
polyacrylamide	(acrylamide	and	bis-acrylamide	29:1),	0.1%	(w/v)	SDS,	0.1%	(v/v)	ammonium	

















	 This	 method	 is	 used	 to	 transfer	 proteins	 from	 an	 SDS-PAGE	 to	 a	 membrane	 for	
further	 visualization	 of	 proteins	 using	 antibodies	 against	 specific	 proteins	 of	 interest	 or	
against	commercial	tags.	
	 In	 this	 work,	 proteins	 were	 transferred	 to	 a	 nitrocellulose	 Trans-Blot®	 Transfer	
Medium	membrane	 or	 to	 a	 methanol	 activated	 Immun-Blot®	 PVDF	 membrane	 (Bio-Rad)	
using	 a	 Trans-Blot®	 TurboTM	 (Biorad)	 semi-dry	 transfer	 apparatus.	 For	 this	 purpose,	 the	
membrane	was	placed	underneath	the	gel	and	four	Whatman	sheets	were	placed	on	the	gel	
and	 under	 the	 membrane,	 all	 soaked	 in	 transfer	 buffer	 (20%	 (v/v)	 methanol	 in	 running	
buffer).	Transference	was	performed	at	25	V	and	1	A	per	mini-gel	during	30	min,	following	a	
quick	 wash	 in	 PBS	 and	 protein	 staining	 with	 Ponceau	 (1%	 (w/v)	 Ponceau	 S	 red,	
5%	(v/v)	glacial	 acetic	 acid).	 The	 stain	 excess	 was	 removed	 with	 subsequent	 washes	 with	
Milli-Q	H2O.	Then,	membrane	was	blocked	with	blocking	solution	(5%	(w/v)	skim	dried	milk	
(Central	Lechera	Asturiana)	in	PBTw	(0.1%	(v/v)	Tween	20	in	PBS))	for	1	h.	Primary	antibodies	
were	 added	 to	 a	 new	 volume	 of	 blocking	 solution	 at	 the	 indicated	 concentration	 and	
incubated	with	the	membrane	for	2h	at	room	temperature	or	overnight	at	4°	C	in	a	humid	
chamber.	 To	 remove	 the	 excess	 of	 primary	 antibodies,	 five	 washes	 of	 10	min	 each	were	
performed	with	PBTw.	
	 Horseradish	 peroxidase	 (HRP)	 coupled	 antibodies	 were	 prepared	 in	 PBTw	 at	 the	
indicated	 concentration	 and	 incubated	 with	 the	 membrane	 for	 at	 least	 45	 min	 at	 room	
temperature,	 following	 three	more	washes	of	 10	min	with	PBTw.	 The	proteins	 of	 interest	
were	revealed	by	chemiluminescence	with	the	ClarityTM	Western	ECL	Substrate	 (Biorad)	kit	




	 To	visualize	proteins	endogenously	expressed	 in	mammal	cells	or	after	 transfection	
of	 expression	 vectors,	 immunofluorescence	 experiments	 were	 performed	 using	 specific	
antibodies	against	the	desired	protein	or	against	commonly	used	tags.	
	 Cells	 cultured	 for	 immunofluorescence	experiments	were	seeded	 in	12x	well	plates	
(Nunc)	with	one	1.9	cm	ø	cover	slide	(Thermo	Fisher)	per	well.	Prior	to	seeding	from	104	to	












in	PBTr	0.1)	during	at	 least	30	min.	Cells	were	 then	 incubated	 for	at	 least	1	h	with	a	new	
volume	of	blocking	solution	supplemented	with	primary	antibodies	at	the	indicated	dilution.	
After	 three	 washes	 of	 5	 min	 with	 PBTr	 0.1,	 secondary	 antibodies	 conjugated	 with	 the	
requested	 fluorophores	 were	 supplemented	 to	 a	 new	 volume	 of	 PBTr	 0.1	 and	 incubated	
with	the	cells	for	at	least	30	min.	After	three	washes	with	PBTr	0.1,	a	last	wash	including	0.1	
µg/ml	4’,	6-diamidino-2-phenylindol	 (DAPI)	was	performed	 to	 stain	 the	nuclei.	 Following	a	
last	 wash	 with	 Milli-Q	 H2O,	 the	 coverslips	 were	 mounted	 on	 a	 microscope	 slide	 using	
VECTASHIELD®	 (Vector)	 and	 nail	 polish	 to	 seal	 the	 coverslips	 and	 slides.	 Once	 sealed,	




	 Immunofluorescence	 was	 also	 employed	 to	 visualize	 proteins	 expressed	 in	 flat	
mounts	from	the	hindbrain	or	transversal	sections	from	the	neural	tube	of	chicken	embryos.	
	 For	 this	 purpose,	 electroporated	 structures	 were	 rehydrated	 through	 subsequent	
washes	of	5	min	using	decreasing	concentrations	of	methanol	(75%,	50%	and	25%	(v/v)),	and	
a	final	wash	using	PBTr	0.25	(0.25%	(v/v)	Triton	X-100	in	PBS)	was	performed.	Then,	 in	the	
case	 of	 transversal	 sections	 be	 needed,	 the	 structures	 were	 included	 in	 4%	 (w/v)	 pure	
agarose	in	PBS	and,	40	µm	sections	were	obtained	using	a	Leica	VT	1000	S	vibratome.	The	
following	procedures	were	performed	in	darkness.	Sections	were	blocked	during	1	h	30	min	
using	1	ml	of	blocking	solution	 (5%	(v/v)	donkey	serum	 in	PBTr	0.25),	 following	 incubation	








min	 with	 PBTr	 0.25,	 a	 final	 wash	 including	 0.1	µg/ml	4’,	6-diamidino-2-phenylindol	 (DAPI)	
was	performed	to	stain	the	cell	nuclei.	Finally,	samples	were	mounted	on	a	microscope	slide	
using	VECTASHIELD®	(Vector)	and	nail	polish	to	seal	the	coverslips	and	slides.	In	the	case	of	
flat	 mounts,	 the	 sections	 were	 dorsally	 dissected,	 prior	 to	 mounting	 them	 on	 the	 slides.	








SUMO1GG,	100	ng	Nab2	and	25	ng	of	Krox20.	All	 this	 components	were	 incubated	 in	 the	














beads	 coupled	 to	 the	 antibodies	 prior	 and	 after	 cross-link	 (Non	 X-link	 and	 X-link,	
respectively)	were	taken	and,	after	centrifugation,	bead	pellets	were	incubated	with	2x	SDS	
sample	buffer	(125	mM	Tris	pH	6.8,	5%	(w/v)	SDS,	0.2%	(w/v)	bromophenol	blue,	25%	(v/v)	






of	 light	 and	heavy	 antibody	 chains	 in	 the	 samples	was	 analysed	by	 SDS-PAGE	 and	 further	
























	 For	 the	 design	 of	 oligonucleotides,	 the	 Primer3Plus	 tool	 (www.bioinformatics.nl/	
cgi-bin/primer3plus/primer3plus.cgi)	 was	 employed.	 For	 the	 analysis	 of	 oligonucleotides,	












was	 performed	 with	 ImageJ32	 1.50i	 (National	 Institute	 of	 Health,	 Bethesda,	 MD).	 Any	
further	 image	 processing	 was	 conducted	 on	 Adobe	 Photoshop	 11.0	 (Adobe	 Systems	
Software).	
	 Gene	Ontology	analysis	was	performed	with	DAVID	6.8	 (Huang	da,	W	 et	al.,	2009).	
Prediction	of	putative	SUMOylation	sites	was	performed	with	GPS-SUMO	1.0	(Zhao,	Q	et	al.,	
2014).	
























































































































































Table	 A-2:	 SUMO1	 SILAC	 candidates.	 Include	data	 from	 identified	SUMO1	 target	proteins	
that	show	a	relevant	SILAC	intensity	ratio.	
	
Table	 A-3:	 SUMO2/3	 SILAC	 candidates.	 Include	 data	 from	 identified	 SUMO2/3	 target	
proteins	that	show	a	relevant	SILAC	intensity	ratio.	
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